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ABSTRACT 
 
The Role of Tumor Necrosis Factor-Alpha in Maladaptive Spinal Plasticity.  
(December 2010) 
John Russell Huie, B.S; M.S., Texas A&M University 
Chair of Advisory Committee: Dr. James W. Grau 
 
Previous work has shown that the spinal cord is capable of supporting a simple 
form of instrumental learning. Subjects that receive controllable shock to an extended 
hind limb will increase the duration of limb flexion over time in order to reduce net 
shock exposure. Exposure to as little as 6 minutes of uncontrollable stimulation prior to 
instrumental testing can elicit a long-lasting learning deficit. Prior work has suggested 
that this deficit may reflect an overexcitation of spinal neurons akin to central 
sensitization, and that learning is inhibited by the saturation of plasticity. The 
experiments in this dissertation were designed to test the role of the cytokine tumor 
necrosis factor alpha (TNF!) in the induction and expression of the deficit. It is believed 
that the inflammatory properties of TNF! may mediate the excitatory processes that lead 
to maladaptive spinal functioning. 
Experiments 1 and 2 tested the necessity of endogenous TNF! in the deficit 
produced by uncontrollable shock. These experiments showed that the inhibition of 
endogenous TNF! blocks both the induction and expression of the shock-induced 
deficit, suggesting a necessary role for TNF! in mediating the inhibition of spinal 
learning. Conversely, Experiment 3 was designed to test the sufficiency for TNF! in 
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producing a learning deficit. I found that treatment with exogenous TNF! undermined 
spinal learning in a dose-dependent fashion, whether given immediately, or 24 hours 
prior to testing. Experiment 4 demonstrated that the long-term TNF!-induced deficit is 
mediated by TNF! receptor activity, as a TNF inhibitor given prior to testing blocked 
the expression of this deficit. 
As TNF! has been shown to be predominantly of glial origin, I next assessed the 
role that glia play in the TNF!-induced deficit. Experiment 5 showed that inhibiting 
glial metabolism prior to TNF! treatment blocked the capacity for TNF! to produce a 
long-term deficit. Experiment 6 assessed the potential for TNF! inhibition to block the 
deficit induced by lipopolysaccharide (LPS), an agent known to induce TNF!. TNF! 
has also been shown to drive neural excitation by increasing the trafficking of calcium-
permeable AMPA receptors to the active zone of the post-synaptic bouton. Experiment 7 
showed that selectively antagonizing these receptors prior to testing blocked the TNF!-
induced deficit, suggesting a possible post-synaptic mechanism by which TNF! exerts 
its effects. 
Finally, histological evidence was sought to reinforce the previous behavioral 
findings. Experiment 8 used quantitative RT-PCR to assess the differential expression of 
TNF! mRNA in uncontrollably shocked subjects as compared to those receiving 
controllable shock and no shock. To determine concentrations of TNF! protein, an 
ELISA was run in Experiment 9 comparing uncontrollably shocked subjects to 
unshocked controls.  
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CHAPTER I 
INTRODUCTION 
Spinal Plasticity: An Overview 
 The spinal cord is no longer viewed as a simple conduit. Instead, research over 
the past 70 years has broadened our understanding of the spinal cord, and has 
enlightened us to its potential for change, growth, and adaptation. In response to a 
barrage of central and peripheral input, the spinal cord is able not only to organize and 
relay signals, but to encode information and affect output. In this way, the spinal cord 
holds the capacity for learning and memory, once believed to be solely entrusted to the 
brain. The idea that the spinal cord is plastic, that it can react to environmental changes 
in a flexible manner that modifies future behavior, has been a hallmark of spinal cord 
research for the past half-century. Early work in spinal plasticity first demonstrated 
simple, single stimulus forms of learning such as habituation and sensitization, and later 
showed that the spinal cord could support more complex associations, including 
Pavlovian and instrumental learning (Fitzgerald & Thompson, 1967; Grau, Barstow & 
Joynes, 1998). 
 One of the main focuses of spinal plasticity research is the capacity for neural 
changes to elicit lasting beneficial effects in response to insult. This adaptive plasticity 
has been most notably studied in spinal cord injury paradigms (Reviewed in Fouad &  
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Tse, 2008). Rossignol and colleagues (1999) first showed that cats with complete spinal 
transections will, over time, exhibit spontaneous locomotor recovery, suggesting an 
intraspinal modification of locomotor circuitry. Other studies revealed that locomotor 
treadmill training of spinalized cats potentiated this adaptive spinal response (Lovely, 
Gregor, Roy, & Edgerton, 1986; de Leon, Hodgson, Roy, & Edgerton, 1998). Although 
these examples most likely reflect long-term spinal reorganization, acute spinal plasticity 
has also been shown to occur. If spinalized cats that are trained on a treadmill are 
presented with an obstacle that hinders their gait, they will quickly learn to alter their 
step in order to avoid the obstacle (Forssberg, Grillner, & Rossignol, 1975).  
 In contrast to the promising potential for adaptive plasticity to protect spinal 
circuitry, the spinal cord also responds to neural insult in a manner that can drive further 
detriment to the system. This maladaptive spinal plasticity can lead to sustained pain 
states, excitotoxicity, and cell death. One of the most common and widely studied 
instances of maladaptive spinal plasticity is the phenomenon of central sensitization. 
Woolf demonstrated that following peripheral inflammation, the threshold for excitation 
in spinal neurons dropped substantially, and that this hyperexcitability was sustained 
long after the initial input (Woolf & Thompson, 1991). This form of nociceptive 
plasticity has been implicated as a mechanism by which neuropathic pain occurs 
(Latremoliere &Woolf, 2009). Maladaptive processes such as central sensitization 
produce long-lasting changes in synaptic efficacy that act to undermine the recovery of 
normal neurotransmission and spinal cord function. Thus, it is important to understand 
the cause and nature of these processes to combat their deleterious consequences. 
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 This dissertation will investigate the neurobiology of maladaptive spinal 
plasticity. Using a behavioral model of spinal plasticity, the experiments in this 
dissertation have been designed to test the necessity and sufficiency of the inflammatory 
cytokine tumor necrosis factor alpha (TNF!) as it pertains to a spinal learning deficit. 
This introduction will provide an overview of the model of spinal plasticity that we have 
used, and highlight insights into maladaptive spinal plasticity that have been fostered 
using this paradigm. The biology and physiological effects of TNF! will then be 
discussed, and the link between spinal plasticity and TNF! will be drawn. Finally, the 
specific aims of this dissertation will be outlined. 
   
Spinal Instrumental Learning 
 Research over the past 50 years has worked to test the limits of the types of 
learning the spinal cord can support. A series of experiments in the 1970’s sought to 
determine if spinal neurons could encode simple response-outcome relations (Chopin & 
Bennett, 1975; Chopin & Buerger, 1975). Although Chopin reported positive results, the 
data were beset by a number of methodological issues (Church & Lerner, 1976). In a 
series of studies, Grau and colleagues addressed these concerns, and provided further 
evidence that the spinal cord could support instrumental learning(Grau, Barstow, & 
Joynes, 1998; Crown, Ferguson, Joynes, & Grau, 2002a; Reviewed in Grau, et al., 
2006).  
 The instrumental learning task used by Grau and  colleagues is a modification of 
a paradigm developed by Horridge in 1962.  In this preparation, shock is delivered to the 
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tibialis anterior muscle of a spinalized rat each time a hind leg is in an unflexed position, 
and shock is terminated when the leg has flexed. Over time, the subject will learn to 
keep the leg in a flexed position that minimizes shock exposure. In this way, spinal 
neurons are capable of encoding the instrumental association between response (flexion) 
and outcome (shock).  
 This simple model of spinal plasticity has a number of distinct advantages. Other 
models of spinal plasticity that use behavioral outcome measures, such as the spinal 
contusion injury model, have difficulties isolating the role of intraspinal changes from 
supraspinal contributions. Conversely, completely isolating spinal neurons in cell culture 
preparations neglects the importance of a behavioral correlate. This spinal instrumental 
learning paradigm strikes an important balance between neurobiology and behavior by 
allowing for pharmacological and physiological manipulations of the isolated spinal 
cord, while also providing a direct behavioral measure of spinal plasticity. Further, the 
findings from this paradigm translate well to more naturalistic spinal cord injury 
preparations, providing clinical relevance to these pursuits (Grau, et al., 2004; Grau, et 
al., 2006). 
 The spinal instrumental learning paradigm also allows for testable predictions 
regarding adaptive and maladaptive forms of spinal plasticity. Instrumental training with 
controllable shock (in which shock delivery is contingent upon leg position) has been 
shown to yield a number of adaptive phenomena, including the facilitation of future 
learning and protection from processes that would normally undermine spinal learning. 
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In contrast, exposure to uncontrollable shock, in which shock is intermittently delivered 
regardless of leg position, can produce a long-lasting maladaptive learning deficit.  
 
The Spinal Learning Deficit 
 The fact that uncontrollable stimulation can undermine adaptive spinal plasticity 
has had implications on the broader field of spinal cord injury research (Grau, et al., 
2004; Grau & Hook, 2006). The administration of as little as 6 minutes of uncontrollable 
shock to the tail of a contused rat has been shown to exacerbate spinal tissue damage and 
undermine functional recovery (Grau, et al., 2004). For this reason, the shock-induced 
learning deficit, and the neurobiological mechanisms that underlie its induction and 
expression, have been a major focus of study for the past decade.  
 The spinal learning deficit was first observed using a master-yoked spinal 
learning preparation. In this setup, the master subject receives controllable shock, 
contingent upon their leg position. Each master subject is experimentally coupled to a 
yoked subject, who receives the same shock as the master, but regardless of leg position. 
In this way, the timing and number of shocks received by each subject is equivalent, and 
the only difference between subjects is controllability. After subjects are trained in this 
fashion, they are both tested with controllable shock. Interestingly, those that had been 
previously exposed to uncontrollable shock are unable to learn the association between 
leg position and shock. This form of maladaptive plasticity is very similar to the 
psychological phenomenon of learned helplessness. This comparison is important, in 
that it highlights a critical feature of this deficit: that uncontrollable shock is producing a 
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form of plasticity, but one that is maladaptive and undermines future learning. This 
notion that the capacity for plasticity itself can be shaped by experience has been 
referred to as metaplasticity (Ferguson, Bolding, et al., 2008).  
 In order to explore the conditions under which this deficit occurs, Crown and 
colleagues set out to isolate the shock parameters necessary to induce the deficit (Crown, 
et al., 2002a). They found that as little as 6 minutes of intermittent shock to the tail could 
induce a deficit that lasted up to 48 hours. It is believed that uncontrollable shock to the 
tail induces a deficit that is dependent upon spinal neurons, as it has been shown that an 
intrathecal injection of lidocaine was sufficient to block the induction of the shock-
induced deficit (Joynes, Ferguson, Crown, Patton, & Grau, 2003).  
 Prior work has also sought to  elucidate the neurobiological systems that are 
involved in the induction and expression of the deficit. Ferguson demonstrated a 
necessary role for the NMDA receptor in the deficit, showing that intrathecal 
administration of the NMDA receptor antagonist MK-801 blocked the induction of the 
deficit (Ferguson, Crown, & Grau, 2006). Further, it was shown that AMPA receptor 
activity was also necessary, and that overexpression of AMPA was sufficient to produce 
a lasting deficit (Hoy, Huie,  & Grau, 2006; Hoy, Huie, Baumbauer, & Grau, 2007). 
Recently, Ferguson outlined a critical role for metabotropic glutamate receptors in the 
deficit as well (Ferguson, Bolding, et al., 2008). Other systems, including opioid and 
GABA activity have also been implicated in playing a role in the deficit (Ferguson, 
Washburn, Crown, & Grau, 2003; Washburn, Maultsby, Puga, & Grau, 2008). 
Interestingly, all of the systems that have been linked to the spinal learning deficit play 
 7 
key roles in excitatory neurotransmission. This insight has led some to theorize that the 
deficit reflects a diffuse overexcitation that saturates spinal circuitry, blocking future 
learning (Ferguson, Crown, & Grau, 2006; Grau, et al., 2006). From this perspective, it 
can be suggested that the deficit produced by uncontrollable shock may be due to a 
central sensitization-like effect. In support of this view, uncontrollable shock has been 
shown to produce a behavioral phenomenon in which normally non-noxious stimuli 
elicit a pain response (allodynia). Likewise, a number of pro-inflammatory 
neurochemical agents have been shown to effectively produce a spinal learning deficit, 
including capsaicin, carrageenan, and an NK1 agonist (Hook, Huie, & Grau, 2008; 
Ferguson, et al., 2006; Baumbauer, Young, Hoy, & Joynes, 2007).  Thus, if the shock-
induced deficit does reflect a form of overexcitation that disrupts future adaptive 
learning, then it will be important to investigate factors that are known to mediate such 
processes.  
 
Tumor Necrosis Factor-Alpha 
 Tumor necrosis factor-alpha (TNF!) has been identified as a potent effector and 
key component in a host of neural processes. Although constitutively expressed on both 
glia and neurons, TNF! is most commonly synthesized and released from microglia and 
astrocytes in response to immune challenge. Following glial activation, TNF! can act 
directly on neurons, as well as in an autocrine fashion to induce glial synthesis of other 
cytokines, such as IL-1, IL-6, as well as the production and release of further TNF! 
(Wallach, et al., 1996; Kuno, et al., 2005; Ji & Suter, 2007).  
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  Post-synaptically, TNF! has been shown to have wide-ranging and varied 
effects on neurons, from promoting cell survival and neuroprotection to excitotoxicity 
and apoptosis (Reviewed in Munoz-Fernandez & Fresno, 1998). TNF! binds to two 
receptor types, TNFR1 and TNFR2. Although their distinct roles have not been fully 
elucidated, it is generally believed that TNFR1 mediates pro-inflammatory and pro-
apoptotic effects, while the lower affinity TNFR2 is responsible for the neuroprotective 
effects of TNF!. These varied functions reflect a complex intracellular signaling 
network, in which TNF! receptor activation can engage a number of distinct pathways 
(Chen & Goeddel, 2002; Ihnatko & Kubes, 2007). Given the many biological contexts in 
which TNF! functions, it is not surprising that TNF! has been implicated in a variety of 
pathologies, including Alzheimer’s disease, ischemic stroke, Parkinson’s disease, cancer, 
and multiple sclerosis (Tsukada, Miyagi, Matsuda, Yanagisawa, & Yone, 1991; Boka, et 
al., 1994; Hallenbeck, 2002).  
     
TNF! and Plasticity 
 One of the main functions of TNF! is to affect change in neurotransmission and 
synaptic strength. TNF! has been shown to modulate ion currents, both directly by the 
coupling of TNFR1 with the NR1 subunit of the NMDA receptor, and indirectly through 
the downstream trafficking of further glutamate receptors. This capacity to affect 
changes in ion concentration and excitability has led many to investigate TNF!’s effect 
on neural plasticity (Albensi & Mattson, 2000; Butler, O’Connor, & Moynagh, 2004). 
When given at high levels, TNF! has been shown to impair long-term potentiation 
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(LTP) in hippocampal slices (Cunningham, Murray, O’Neil, Lynch, O’Connor, 1996). 
Conversely, TNF receptor knockout mice show impaired hippocampal long-term 
depression (Albensi & Mattson, 2000). Behaviorally, TNF! overexpression in the 
hippocampus has been shown to  impair spatial learning and memory (Golan, Levav, 
Mendelsohn, & Huleihel, 2004).  
 TNF! has also been shown to affect neural changes related to nociceptive 
signaling. Although shown to impair LTP in the hippocampus, exogenous TNF! 
administration in the dorsal horn of the spinal cord can induce LTP of C-fiber evoked 
field potentials (Liu, et al., 2007). Further data have shown TNF! to cause an increase in 
transient voltage-gated sodium channel currents on primary afferents, and this action has 
been suggested to underlie the induction and maintenance of neuropathic pain following 
nerve injury (Czeschik, Hagenacker, Schafers, & Busselberg, 2008). 
 In 2002, Beattie and colleagues demonstrated that TNF! plays a critical role in 
the regulation of AMPA receptor trafficking, which in turn dictates synaptic strength. 
Stellwagen and Malenka (2006) extended these findings when they observed that after 
neural activity falls, glia work to increase TNF! release in order to globally scale 
synapses up through AMPAR trafficking to the active region of the post-synaptic bouton  
(Turrigiano, 2008).  
 Although this excitatory role of TNF! provides a regulatory mechanism under 
normal conditions, the overexpression of TNF! in response to neural insult creates 
excitotoxic consequences that severely undermine adaptive plasticity (Perry, Collins, 
Wiener, Acton, & Go, 2001; Leonoudakis, Zhao, & Beattie, 2008).  TNF! specifically 
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promotes the trafficking of AMPA receptors that lack the GluR2 subunit (Ogoshi, et al., 
2005). Without this subunit, these AMPA receptors are calcium permeable (Hollmann, 
Hartley, & Heinemann, 1991). The overexpression of Glur2-lacking AMPARs has been 
shown to induce maladaptive synaptic plasticity in both the brain and spinal cord (Galan, 
Laird, & Cervero, 2004).  By increasing the amount of Glur2-lacking AMPA receptors 
on the membrane, TNF! can induce excitability by setting a neural environment that is 
vulnerable to glutamate-mediated calcium influx. This mechanism has recently been 
implicated in the induction and maintenance of neuropathic pain following peripheral 
nerve injury, as well as undermining recovery of function following spinal contusion 
injury (Choi, Svensson, Koehrn, Bhuskute, & Sorkin, 2010; Ferguson, et al., 2008).   
 
Specific Aims 
 This set of experiments is designed to assess the role of TNF! in the maladaptive 
effect of uncontrollable stimulation. The central hypothesis of this dissertation is that 
uncontrollable shock induces glial release of TNF!, and that TNF! acts post-
synaptically to induce a long-lasting AMPAR-mediated overexcitation that undermines 
future adaptive plasticity. This study assessed behavioral, pharmacological, and 
histological outcomes to determine the role of TNF! in the spinal learning deficit. 
 From a behavioral perspective, if TNF! mediates the shock-induced deficit, then 
endogenous TNF! should be necessary in order for uncontrollable shock to elicit a 
deficit. A TNF! inhibitor was used in Experiments 1 and 2 to determine if the deficit 
would be induced and expressed in the absence of endogenous TNF!. Expanding on 
 11 
these results, Experiment 3 tested whether exogenous TNF! would be sufficient to 
substitute for uncontrollable shock in order to produce both an acute and long-term 
deficit. Experiment 4 examined the nature of a long-term TNF!-induced deficit by 
investigating whether the expression of this deficit was TNF! mediated.  
 Next, the mechanisms by which TNF! exerts maladaptive effects were assessed. 
Prior work has shown endogenous TNF! release to be predominantly of glial origin. 
Additionally, it has been shown that TNF! can act on microglia in an autocrine fashion 
that causes further TNF! production and release. Thus, if the long-term TNF!-induced 
deficit is mediated by glial release of TNF!, then inhibiting glia should attenuate this 
deficit. This hypothesis was tested in Experiment 5, in which the glial metabolic 
inhibitor fluorocitrate was given prior to TNF! treatment. Experiment 6 tested whether 
TNF inhibition could block the expression of the deficit induced by lipopolysaccharide 
(LPS), an agent known to induce endogenous TNF! release. 
  I then assessed a possible post-synaptic effect of TNF! treatment. As mentioned 
previously, TNF! has been shown to act post-synaptically through the receptor TNFR1 
to elicit trafficking of calcium permeable AMPA receptors to the membrane (Ogoshi, et 
al., 2005; Choi, et al., 2010). Experiment 7 assessed the possibility that this increase in 
calcium-permeable AMPA receptor populations to the cell surface is a TNF!-induced 
outcome that is necessary in order for TNF! to produce a deficit. Following TNF! 
treatment, an antagonist specific to calcium-permeable AMPA receptors was given to 
assess the role  of this phenomenon in the spinal learning deficit.  
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 Finally, histological techniques were used to assess the cellular evidence for the 
role of TNF! in the deficit. If TNF! mediates the deficit induced by uncontrollable 
shock, then it is expected that uncontrollable shock will cause an increase in endogenous 
TNF! populations. Experiment 7 used reverse transcriptase polymer chain reaction (RT-
PCR) to assess whether uncontrollable shock upregulates TNF! mRNA production. 
Experiment 8 assessed levels of TNF! protein at three time points following 
uncontrollable shock in order to determine a timecourse by which TNF! expression 
occurs. 
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CHAPTER II 
GENERAL METHOD 
Subjects 
 Male Sprague-Dawley rats obtained from Harlan (Houston, TX) served as 
subjects. Rats were approximately 100-120 days old and weighed between 360 and 460 
g. They were housed individually and maintained on a 12-hour light/dark cycle, with all 
behavioral testing performed during the light cycle. Food and water was available ad 
libitum. 
 
Surgery 
Subjects were anesthetized with isoflurane. The 2nd thoracic vertebrae (T2) was 
located by touch and a 2.5 cm anterior-posterior incision was made over T2. The tissue 
immediately rostral to T2 was cleared, exposing the spinal cord. A cautery was then used 
to transect the cord, and the cavity filled with Gelfoam (Harvard Apparatus, Holliston, 
MA). A 25cm polyethylene cannula (PE-10, VWR International, Bristol, CT) was 
subsequently threaded 9cm down the vertebral column, into the subarachnoid space 
between the dura and the white matter so that it lies on the dorsal surface of the spinal 
cord. The incision was closed using Michel clips (Fine Science Tools Foster, CA), and 
the exposed end of cannula tubing fixed to the skin with cyanoacrylate.  
 Immediately following surgery, subjects received an injection of 0.9% saline 
(2.5ml, i.p.). During recovery, the hindlimbs were maintained in a normal flexed 
position using a piece of porous orthaletic tape, wrapped gently around the rat’s body. 
 14 
The recovery period was 24 hours, throughout which the rats were housed in a 
temperature-regulated environment (25.5° C). Supplemental saline injections were 
provided to ensure proper hydration, and bladders expressed twice daily, and just before 
behavioral testing. Complete transection were confirmed by a) visually inspecting the 
cord during surgery, b) observing behavior following recovery, ensuring subjects exhibit 
paralysis caudal to the site of transection, and do not vocalize when shock is 
administered to the tail or hindpaw, c) examining the transection site postmortem in a 
randomly selected subset of subjects. 
 
Apparatus 
Instrumental Training and Testing   
Instrumental testing was conducted while rats were loosely restrained in tubes 
(23.5 cm [length] x 8 cm [internal diameter]). Two slots in the tube, (5.6 cm [length] x 
1.8 cm [width]), 4 cm apart, 1.5 cm from the end of the tube, allowed both hind legs to 
hang freely. To minimize the effects of upper body movement on leg position, a wire 
belt was secured to the rat’s trunk within the tube. Leg shock was delivered using a 
BRS/LVE (Laurel, MD) constant current (60Hz, AC) shock generator (Model SG-903).  
Two electrodes inserted over the tibialis anterior muscle were connected to a computer-
controlled relay that regulated the application of leg shock. 
 Leg position was monitored during testing using a contact electrode constructed 
from a 7 cm long, 0.46 mm diameter stainless steel rod taped to the foot. The last 2.5 cm 
of the electrode was insulated from the foot with heat shrink tubing. A fine wire (0.01 sq 
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mm [36 AWG] (20 cm) attached to the end of the rod extended from the rear of the foot 
and connected to a digital input monitored by a Macintosh computer. A plastic 
rectangular dish (11.5 [w] x 19 [l] x 5 [d]) containing a NaCl solution was placed 
approximately 7.5 cm below the restraining tube. A drop of soap was added to the 
solution to reduce surface tension.  A ground wire was connected to a 1 mm wide 
stainless steel rod, which was placed in the solution. When the contact electrode attached 
to the rat's paw touched the solution, it completed the circuit monitored by the computer, 
delivering a shock to the tibialis anterior. The state of this circuit was sampled at a rate 
of 30 times/s. 
 Flexion force was measured by attaching a monofilament plastic line ("4 lb test" 
Stren, Dupont, Wilmington DE) to the rat's foot immediately behind the plantar 
protuberance. The 40 cm length of line passed through an eyelet attached to the 
apparatus directly under the paw, 16 cm beneath the base of the tube. The end of the line 
was attached to a strain gauge (Fort-1000, World Precision Instruments, New Haven, 
CT) fastened to a ring stand. After the line was connected to the rat's paw, the ring stand 
was positioned so that the line was taut, just barely registering on the gauge. The strain 
gauge was calibrated by determining the relationship between voltage and force in 
Newtons. These data revealed a linear relation, which allowed us to convert voltage to 
force. 
 
Uncontrollable Tailshock 
 Uncontrollable shock was administered while rats were loosely restrained in 
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opaque black Plexiglas tubes that are 22 cm in length and 6.8 cm in diameter. A flat 
floor constructed from a sheet of black Plexiglas 5.5 cm wide was attached 5.3 cm below 
the top of the tube. Tailshock was delivered using an electrode constructed from a 
modified fuse clip. The electrode was coated with ECG gel (Harvard Apparatus, 
Holliston, MA) and secured with porous tape approximately 6 cm behind the base of the 
tail. Constant-current 1.5-mA shock was delivered using a 660-V transformer.  A 
Macintosh computer controlled the onset and offset of shock.  
 
Instrumental Learning Testing Procedure 
 All subjects were allowed to recover for 24 h following surgery and the 
hindlimbs were shaved and marked for electrode placement prior to testing. A wire 
electrode was then inserted through the skin over the distal portion of the tibialis anterior 
(1.5 cm from the plantar surface of the foot), and one lead from the generator was 
attached to this wire.  A contact electrode was secured to the foot between the second 
and third digits with a piece of porous tape. The shock generator was set to deliver a 0.4 
mA shock, and the proximal portion of the tibialis anterior (approximately 1.7 cm 
proximal to the wire electrode) was probed with a 2.5-cm stainless steel pin attached to a 
shock lead to find a robust flexion response. The pin was then inserted 0.4 cm into the 
muscle. A strain gauge was utilized to verify that a single, intense (1.6 mA, 0.3 s) test 
shock can elicit at least a 0.8 N flexion force, and to determine the amount of shock 
necessary to elicit a 0.4 N flexion force.   
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To minimize lateral leg movements, a 20 cm piece of porous tape was wrapped 
around the leg and attached to a bar extending across the apparatus directly under the 
front panel of the restraining tube. The tape was adjusted so that it was taut enough to 
slightly extend the knee. Finally, three short (0.15 s) shock pulses were applied and the 
level of the salt solution was adjusted so that the tip of the contact electrode (attached to 
the rat’s foot) was submerged 4 mm below the surface. A rat’s capacity to perform the 
instrumental response was then tested with exposure to 30 min of controllable shock. 
Whenever the rat’s leg fell below the level of the salt solution, the electrodes delivered a 
shock to the tibialis anterior muscle causing the ankle to flex. Leg position was 
monitored using a Macintosh computer at a sampling rate of 30 Hz. 
 
Behavioral Measures 
 Three behavioral measures, response number, response duration and time in 
solution, were used to assess a subject’s capacity to perform the instrumental response 
(see Grau, et al., 1998). Performance was measured over time in 30 1-min time bins.  
The computer monitoring leg position recorded an increase in response number 
whenever the contact electrode was raised above the salt solution. Response duration 
was derived from time in solution and response number using the following equation: 
Response Durationi = (60 s – time in solutioni)/(Response Numberi + 1) where i is the 
current time bin. 
 To evaluate whether our experimental treatment affected baseline behavioral 
reactivity, we analyzed both the shock intensity required to elicit a flexion force of 0.4 N 
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and the duration of the first shock-elicited flexion response. Independent ANOVAs  
showed that there were no group differences on either measure across all experiments, 
Fs < 2.58, p < 0.05. 
Histology 
RT-PCR 
  Total RNA was isolated from tissues using the Trizol method (#15596-026 
Invitrogen). Total RNA from each sample was purified with Qiagen’s RNeasy MiniKit 
(#74104) and quantified by micro- fluidic separation (Agilent BioAnalyzer). Total RNA 
(1ug) was reverse-transcribed with the First-Strand cDNA Synthesis system for RT-PCR 
(#12371-09 Invitrogen) and SuperScript II Rnase H-Reverse Transcriptase (#18064-014 
Invitrogen). Prior to real-time PCR analysis, forward and reverse primers for selected 
genes were analyzed using the Beacon Designer v.3 software (Premier BioSoft 
International). Primers were selected from a list of suggested primers only if the primer 
sequences cross intron-exon boundaries to eliminate secondary structure formation and 
amplification of genomic DNA. Selected primers were then optimized by a standard 
curve using serial dilutions of the template to determine the amplification efficiency of 
the PCR reaction. Single product formation was be verified by melt curve analysis.  For 
real-time PCR, cDNA, forward and reverse primers, and BioRad’s iQ Syber Green 
Supermix (#170-8882) were combined and analyzed with the iCycler MyiQ system from 
BioRad. Beta-actin served as the reference gene and the control condition served as the 
normalization control sample.   
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ELISA 
  TNF! levels were assessed using the TNF! immunoassay kit from R & D 
Systems (Minneapolis, MN). Briefly, tissue samples were homogenized in cold lysis 
buffer (phosphate-buffered saline, pH 7.4, with 1% Triton-X 100 and protease inhibitor 
cocktail). Supernatants were obtained by centrifugation (13,000g for 15 min at 2° C) and 
stored at –80° C until assays were conducted according to kit instructions. Absorbance 
was measured on a Victor 2 microplate reader (PerkinElmer) and TNF concentrations 
were normalized to total protein determined with the bicinchonic acid (BCA) method.    
 
Statistics 
 All data was analyzed using repeated measures analysis of variance (ANOVA). 
An alpha value of .05 or below was considered significant. Differences between group 
means were assessed using Duncan’s New Multiple Range post hoc tests when 
necessary.  
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CHAPTER III 
ENDOGENOUS TNF!: BEHAVIORAL CONTRIBUTION TO THE SPINAL 
LEARNING DEFICIT 
Experiment 1 
 The experiments in this dissertation were designed to test whether TNF! 
mediates the spinal learning deficit produced by uncontrollable shock. In order to 
comprehensively assess the behavioral role of TNF! in the spinal learning deficit, it is 
important to first test the necessity for endogenous TNF! in this phenomenon. 
Experiment 1 was designed to test whether uncontrollable shock can produce a deficit in 
the absence of functional endogenous TNF!. If TNF! is necessary in order for 
uncontrollable shock to cause a learning deficit, then inhibiting TNF! prior to 
uncontrollable shock should block the induction of this deficit. 
 
Procedure 
Experiment 1 used 32 rats (n=8). Twenty-four hours after complete transection, 
subjects received an intrathecal injection of either the soluble TNF receptor sTNFR1 
(350 ng) or saline vehicle in 10 !L, followed by a 20 !L saline flush. Forty-five minutes 
later, subjects received either 6 minutes of uncontrollable shock or an equivalent period 
of unshocked restraint. All subjects were then immediately tested for instrumental 
learning. 
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Results 
 The effect of endogenous TNF! inhibition on the shock-induced deficit is 
depicted in Figure 1. As expected, vehicle-treated unshocked subjects were able to learn. 
Likewise, the TNF inhibitor sTNFR1 alone had no detrimental effect on the acquisition 
of the instrumental response. Vehicle-treated subjects that received uncontrollable shock 
exhibited a pronounced learning deficit. Interestingly, those subjects that received the 
TNF! inhibitor prior to uncontrollable shock were able to learn. An ANOVA did not 
reveal a significant main effect of drug or shock treatment, nor did it reveal a significant 
Drug X Shock interaction. There was, however, a main effect of trials, and a significant 
three-way interaction between trials, drug, and shock, Fs > 1.54, p < .05. This interaction 
indicates that learning (the change in flexion duration over time) is dependent on both 
shock and TNF! inhibitor treatment. No other interactions were significant, p > .05.  
The number of responses made by each subject was also assessed (Figure 1B). 
On average, subjects that exhibited the learning deficit exhibited the highest rate of 
responding, while those that learned responded less frequently. The difference in total 
response number was assessed using an ANOVA, revealing main effects of drug, shock, 
and trials, as well as significant Drug X Shock, Trials X Drug, and Trials X Drug X 
Shock interactions and  Fs > 2.02, p < .05.  Post hoc analysis of group means showed 
that vehicle shocked subjects were significantly different from all other groups, p < .05. 
The higher response numbers for subjects that failed is due to the fact that these subjects 
had shorter response durations, and were therefore exposed to shock more often. This 
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Figure 1. Effect of TNF" inhibition on the shock-induced deficit. Vehicle groups are 
shown in white, sTNFR1-treated groups in black. In the left panel, unshocked groups are 
represented with circles, shocked groups with triangles. A) Left panel depicts response 
durations over time. Right panel depicts mean response durations for each group, 
collapsed over time. Data indicate that sTNFR1 treatment blocks the shock-induced 
deficit. B) Left panel depicts response number over time, right panel depicts mean 
response number for each group. Data show that subjects who failed had higher response 
numbers, confirming that these subjects are not exhibiting a deficit in response 
performance. 
finding is important, as it shows that the failure to exhibit increased response durations is 
not due to a lack of responding, and therefore not a performance deficit. Because all  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
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subsequent experiments yielded a similar, inverse, relationship between response 
duration and response number, only the former is reported. 
 
Discussion 
 These data provide behavioral evidence for the role of TNF! in the detrimental 
effects of uncontrollable shock. Blocking endogenous TNF! action prior to 
uncontrollable shock protected against the induction of the behavioral deficit, suggesting 
that TNF! receptor activation is necessary in order for the shock-induced deficit to 
occur.  
 
Experiment 2 
 Experiment 1 demonstrated a necessity for endogenous TNF! in order for 
uncontrollable shock to produce a deficit immediately following stimulation. Expanding 
on that experiment, Experiment 2 is designed to further assess the role of TNF! in the 
deficit by examining the long-term effect of a TNF! inhibitor when given either prior to 
uncontrollable shock or prior to testing. In this way, the current experiment tests whether 
endogenous TNF! is necessary in order for uncontrollable shock to induce the deficit, as 
well as test the possibility that TNF! is necessary in order for the deficit to be expressed 
following uncontrollable shock. 
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Procedure 
Experiment 2 used 48 rats (n =8). The design of this experiment is depicted in 
Figure 2. To test the long-term effect of uncontrollable shock, two groups were given 
vehicle injections, followed 45 minutes later with either uncontrollable shock or none. 
Twenty-four hours later, subjects were given a second vehicle injection, followed by 
instrumental testing. To test the effect of TNF! inhibition on the induction of deficit, 
two groups were given sTNFR1, followed 45 minutes later with uncontrollable shock or 
none. Twenty-four hours later, subjects were given a vehicle injection, followed by 
instrumental testing. Finally, to test the effect of TNF! inhibition on the expression of 
the deficit, two groups were given vehicle injections, followed 45 minutes later  with 
uncontrollable shock or none. Twenty-four hours later, subjects received an intrathecal 
injection of sTNFR1, followed by instrumental testing. This design allowed us to: a) 
verify that shock treatment inhibits learning 24 hours later, b) test whether sTNFR1 
Figure 2. Experimental design for experiment 2. 
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before shock blocks the induction of the deficit, and c) test whether sTNFR1 after shock 
blocks the expression of the deficit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effect of TNF" inhibition on the induction and expression of the shock-
induced deficit. Unshocked groups are shown in white, shocked groups are shown in 
black. A) Response durations over time for subjects receiving vehicle only. B) 
Response durations over time for groups that received sTNFR1 prior to shock 
treatment. C) Response durations over time for groups receiving sTNFR1 prior to 
testing. D) Mean response durations for all groups collapsed over time. Data indicate  
that sTNFR1 treatment blocks the induction and expression of the shock-induced 
deficit.  
A 
C 
B 
D 
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Results 
Induction. The design of this experiment allowed for the same shocked and unshocked 
vehicle-treated controls to be compared to both the induction and expression groups in 
the subsequent analyses. As expected, prior exposure to intermittent shock inhibited 
learning when subjects were tested 24 hours later (Figure 3A). 
 The effect of TNF! inhibition on the induction of the shock-induced deficit is 
depicted in Figure 3B. Administration of the TNF! inhibitor sTNFR1 alone had no 
detrimental effect on learning. Rats that received the TNF! inhibitor prior to 
uncontrollable shock were also able to learn. An ANOVA revealed main effects of drug, 
shock condition, and trials, F > 3.45, p < .05. Further, the Trials X Shock interaction and 
the Trials X Drug X Shock interaction were both significant, F (29,812) > 2.38, p < .05. 
Post hoc comparison of the group means confirmed that the vehicle shocked group 
differed significantly from all other groups, p < .05. No other effects were significant, p 
> .05. 
 
Expression. The effect of TNF! inhibition on the expression of the shock-induced 
deficit is depicted in Figure 3C. As in the induction groups, those that received sTNFR1 
alone had no impairment in learning. Surprisingly, those that received uncontrollable 
shock followed by sTNFR1 prior to testing were also able to learn. An ANOVA 
comparing these groups to the vehicle controls revealed a significant main effect of 
trials, as well as a significant Trials X Shock interaction, F (29, 812) > 2.27, p < .01. 
Post hoc comparison of the group means confirmed that the vehicle shocked group 
 27 
differed significantly from all other groups, p < .05. No other effects were significant, p 
> .05.  
 
Discussion 
 The protective effect of TNF! inhibition found in the induction groups of this 
experiment extends the findings from Experiment 1, in which sTNFR1 was previously 
shown to protect against the shock-induced deficit when subjects were tested 
immediately following shock. Here, this protective effect was evident when subjects 
were tested 24 hours after shock administration.  
 Beyond the protective effect of TNF! inhibition, this experiment also 
demonstrates that sTNFR1 can provide a therapeutic effect, blocking the expression of 
the shock-induced deficit when given 24 hours after uncontrollable shock. The capacity 
for TNF! inhibition to restore learning long after the deficit has been induced suggests 
that uncontrollable shock may not only cause TNF! release, but that this release may be 
sustained. That learning can be rescued by blocking TNF! receptor activity also 
suggests that the role for TNF! in the deficit is not a transient one. Rather than TNF! 
acting as a intermediary in a cascade that leads to an immutable intracellular 
modification, it appears that TNF! receptor activity may be a lynchpin of the 
mechanism that produces the shock-induced deficit, and sustained TNF! receptor 
activation is required in order for the deficit to be expressed. 
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CHAPTER IV 
BEHAVIORAL IMPACT OF EXOGENOUS TNF! ON THE SPINAL LEARNING 
DEFICIT 
Experiment 3 
 It has been shown that the overexpression of TNF! can lead to a robust increase 
in neural excitability that ultimately undermines learning (Leondoukis, et al., 2008). 
Similarly, a number of pharmacological agents that are known to induce the spinal 
learning deficit have been correlated with increased TNF! release (Cocchiara, et al., 
1999; Hwang, Lee, Kim, Shim, & Hahm, 2008; Elliott, et al., 2009). The previous two 
experiments outlined a necessary role for TNF! in the shock-induced deficit, showing 
that the inhibition of endogenous TNF! can block the induction and expression of the 
deficit. In order to get a comprehensive view of the degree to which TNF! mediates the 
spinal learning deficit,  it is also important to examine the sufficiency for TNF! in this 
phenomenon. Experiment 3 tests whether administration of exogenous TNF! can 
substitute for uncontrollable shock to produce a learning deficit. 
 
Procedure 
Experiment 3 used 48 rats (n =8). Twenty-four hours after complete transection, 
subjects received an intrathecal injection of one of three doses of TNF!  (0, 600, or 6000 
pg) in 10 !L, followed by a 20 !L saline flush. Subjects were then tested for 
instrumental learning either 45 minutes after injection, or 24 hours after injection. 
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Figure 4. Immediate and long-term effect of exogenous TNF" treatment on 
instrumental learning. Left panels depict response durations over time. Right panels 
depict mean response durations for each group, collapsed over time. Vehicle-treated 
groups are shown in white, 600 pg dose in gray, 6000 pg dose in black. A) Response 
durations for groups receiving exogenous TNF" 45 minutes prior to testing. B) 
Response durations for groups receiving exogenous TNF" 24 hours prior to testing. 
Data indicate that exogenous TNF" undermines learning in a dose-dependent 
fashion, both immediately and 24 hours after treatment. 
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Results 
 The effect of exogenous TNF! treatment on instrumental learning is depicted in 
Figure 4. As expected, the subjects that were given the 0 ng dose (vehicle) were able to 
learn. All other groups failed to learn. An ANOVA revealed main effects of drug 
treatment and trials, as well as a significant Drug X Trials interaction, Fs > 1.37, p < .05. 
Post hoc analyses of the group means also showed a significant difference between the 
highest dose of TNF! and the lowest dose (vehicle), at both the immediate and 24 hour 
time points, p < .05. No other effects were significant, p > .05. 
 
Discussion 
 The previous two experiments demonstrated that endogenous TNF! was 
necessary to produce a shock-induced deficit. Here we expand on those findings by 
showing that administration of TNF! is sufficient to produce both an acute and long-
term deficit. The highest doses tested at either timepoint caused a deficit that is 
commensurate with the level of impairment seen in uncontrollably shocked subjects. 
This experiment lends further evidence that TNF! release and receptor activity may 
mediate the maladaptive behavioral effect of uncontrollable stimulation.  
 The finding that TNF! can produce a long-term deficit is especially interesting, 
because 24 hours should be long enough for the drug to clear he system. From this 
perspective, these data suggest that exogenous TNF! may engage other maladaptive 
processes that extend and sustain the period in which the deficit can be expressed. This 
idea is supported by others who have shown that high levels of TNF! can elicit a 
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persistent disruption in neural plasticity (Butler, O'Connor, & Moynagh, 2004). 
Similarly, Ji & Suter (2007) have also shown that TNF! treatment can produce a 
prolonged deficit in normal neural function, and have suggested an intriguing underlying 
mechanism. They have shown that TNF!, acting on microglia, can lead to the 
production and release of further TNF!, creating an autocrine feedback loop that 
sustains high levels of extracellular TNF! for an extended period of time. My next 
experiment explores whether this mechanism underlies the long-term effect of 
exogenous TNF! treatment on spinal learning. 
 
Experiment 4 
 Prior work has shown that TNF! administration can lead to an increased 
expression of endogenous TNF! stores (Kuno, et al., 2005). Such sustained TNF! 
activity could mediate the long-term TNF!-induced learning deficit that was observed in 
Experiment 3. If sustained TNF! activity is responsible for the TNF!-induced deficit, 
then it would be expected that the expression of the deficit could be blocked by 
inhibiting TNF! prior to testing. Experiment 4 was designed to address this possibility, 
testing whether the long-term effect of TNF! treatment can be blocked by a TNF!-
inhibitor prior to testing. 
 
Procedure 
 This experiment used 48 rats (n =8). Twenty-four hours after complete 
transection, subjects received an intrathecal injection of TNF! (6000 pg) or vehicle in 10 
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!L, followed by a 20 !L saline flush. Twenty-fours later, subjects were given the TNF! 
inhibitor sTNFR1 or vehicle intrathecally (10 !L) 45 minutes prior to testing. Because 
pilot data indicated a 350 ng dose of sTNFR1 had a partial effect,  I included two 
additional groups that were treated with a higher dose (700 ng) of sTNFR1 prior to 
testing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Effect of TNF" inhibition on the TNF"-induced deficit. Left panel shows 
response durations for groups that received vehicle injections prior to sTNFR1 treatment. 
Right panel shows response durations for groups that received TNF" treatment prior to 
sTNFR1 treatment. Bottom panel depicts mean response durations for all groups collapsed 
over time. Data indicate that the  expression of the TNF"-induced deficit can be blocked by 
sTNFR1 treatment. 
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Results 
 The effect of TNF! inhibition on the TNF!-induced deficit is depicted in Figure 
5. As expected, subjects that received only vehicle injections were able to learn. Vehicle-
treated subjects that received sTNFR1, at either dose, also learned. Subjects given TNF! 
alone exhibited a learning deficit when tested 24 four hours later replicating the finding 
from Experiment 3. Interestingly, TNF!-treated subjects that were given sTNFR1 prior 
to testing were able to learn. An ANOVA revealed a significant main effect of both TNF 
treatment and trials, F > 6.75, p < .05. Although no other main effects or interactions 
were significant, the interaction between TNF treatment and sTNFR1 treatment 
approached significance (F (2,42) = 3.13, p = .054). To further explore this relationship 
trend analyses were run. These analyses revealed that the linear component of the Trials 
X TNF X sTNFR1 interaction was significant, F = 10.42, p < .01. The trend analyses 
also showed the quadratic component of the Trials X sTNFR1 interaction to be 
significant, F =5.81, p < .05. Finally, a post hoc comparison of the group means revealed 
that the group that received TNF! alone differed significantly from all other groups, p < 
.05. 
 
Discussion 
 As in Experiment 2, this experiment showed the therapeutic capacity of TNF! 
inhibition after a learning deficit has been induced. More importantly, it demonstrates 
that TNF! receptor activity is still required 24 hours after TNF! treatment in order for 
the deficit to be expressed. This finding lends further evidence to the possibility that 
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exogenous TNF! administration may elicit an increased expression of endogenous 
TNF! that outlasts the initial treatment.  
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CHAPTER V 
MECHANISMS OF ACTION: GLIAL AND POST-SYNAPTIC EFFECTS OF TNF! 
Experiment 5 
 In other preparations, the feedback loop that underlies the long-term effects of 
TNF! treatment depends on glial release of endogenous TNF! (Kuno, et al., 2005). 
Further, if TNF! underlies the long-term effect of uncontrollable shock, then the 
maintenance (memory) of that effect should depend on glial activity. Supporting this, 
Vichaya et al. (2009) have shown that the glial inhibitor fluorocitrate inhibits the long-
term consequence of uncontrollable shock. Experiment 5 explores whether the 
administration of fluorocitrate prior to TNF! treatment will block its long-term effect on 
instrumental learning. 
 
Procedure 
 This experiment used 24 rats (n =6). Twenty-four hours after complete 
transection, subjects received an intrathecal injection of either the glial inhibitor 
fluorocitrate (0.5 nmol) or vehicle in 10 !L, followed by a 20 !L saline flush. Forty-five 
minutes later, subjects received TNF! (6 ng) or vehicle, followed by a 20 !L flush. All 
subjects were then tested for instrumental learning 24 hours later. 
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Results 
 The effect of glial metabolic inhibition on the TNF!-induced learning deficit is 
shown in Figure 6. Subjects that only received vehicle treatment were able to learn as 
expected. Likewise, those subjects that received fluorocitrate alone also learned,  
 
 
 
 
 
 
 
 
 
 
 
 
replicating prior findings (Vichaya, Baumbauer, Carcoba, Grau, & Meagher, 2009). 
Subjects receiving TNF! alone exhibited a marked decrease in flexion duration, and this 
deficit was attenuated in subjects that received fluorocitrate prior to TNF! treatment. 
Although there were no significant main effects of TNF! or fluorocitrate (F (1,20)< 
1.99, p > .05), an ANOVA revealed a significant interaction between drug treatments, F 
(1,20) = 6.30, p < .05. There was a significant main effect of trials, as well as a 
Figure 6. Effect of glial metabolic inhibition on the TNF"-induced deficit. Left 
panel depicts response durations over time. Right panel depicts mean response 
durations for each group, collapsed over time. Groups that received initial injections 
of vehicle are shown in white, those that received fluorocitrate are shown in black. 
For the second injection, groups that received vehicle are represented by circles, 
those that received TNF" are represented by triangles. Data indicate that 
fluorocitrate treatment prior to TNF" blocks the induction of the deficit.  
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significant interaction between trials, TNF!, and fluorocitrate treatment, F (29, 580) > 
1.62, p < .05. Post hoc analysis of group means showed that subjects receiving TNF! 
alone differed significantly from those that received vehicle alone, as well as those who 
received fluorocitrate prior to TNF! treatment, p < .05. No other differences approached 
significance, p > .05. 
 
Discussion 
 This experiment demonstrates the necessity for glial metabolism in order for 
TNF! treatment to produce a long-term spinal learning deficit. This finding is 
significant, in that it highlights a critical component of the maladaptive mechanism by 
which TNF! works to undermine learning. Taken together with the previous experiment, 
which showed that the long-term deficit requires continued TNF receptor activity, the 
current experiment provides further evidence that TNF! treatment may lead to sustained 
glial release of endogenous TNF!. 
 
Experiment 6 
 The previous experiments have shown TNF" to be sufficient to produce a 
learning deficit, and that glial activation is necessary to produce this effect. In order to 
further understand the natural interaction between glial activation, TNF" release, and the 
expression of the deficit, it is important to investigate methods that may cause glial-
mediated TNF" release. Administration of the potent microglial activator 
lipopolysaccharide (LPS) is known to cause an increase in TNF! protein levels in the 
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spinal cord (Shen, et al., 2008). It has also been previously shown that LPS is sufficient 
to produce a spinal learning deficit (Young, Baumbauer, Elliot, & Joynes, 2007). 
Experiment 6 is designed to test whether TNF! inhibition prior to testing is sufficient to 
block the LPS-mediated deficit. 
 
Procedure 
 This experiment used 24 rats (n = 6). Twenty-four hours after complete 
transection, subjects were given an intrathecal injection of either 100 !g LPS in 10 !L 
saline or vehicle, followed by a 20 !L saline flush. Twenty-four hours later, subjects 
were administered an intrathecal injection of either sTNFR1 (350 ng) or saline vehicle in 
10 !L, followed by a 20 !L saline flush. All subjects were then tested for instrumental 
learning. 
 
 
 
 
 
 
 
 
 
 
Figure 7. Effect of TNF" inhibition on the LPS-induced deficit. Left panel depicts 
response durations over time. Right panel depicts mean response durations for each 
group. Subjects that received an initial injection of vehicle are shown in white, subjects 
that received LPS are shown in black. Subjects that received vehicle as a second 
injection are represented by circles, subjects that received sTNFR1 are represented by 
squares. Data indicate that LPS produces a mild deficit, and sTNFR1 treatment has a 
slight therapeutic effect. 
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Results 
 The effect of TNF inhibition on the LPS-induced deficit is depicted in Figure 7.  
Subjects that received sTNFR1 or vehicle alone were able to learn. Rats receiving LPS 
alone had shorter response durations than all other groups, but did not exhibit as robust 
of a deficit as has been shown previously. Subjects in which TNF! was inhibited 
following LPS treatment had longer response durations than those receiving LPS alone, 
but were unable to learn as well as the controls. An ANOVA revealed a main effect of 
trials, F(29, 551) = 2.64,  p < .05. None of the other main effects, or interactions, were 
significant, all Fs < 1.71, p > .05. 
 
Discussion 
 Although TNF! inhibition caused LPS-treated rats to exhibit slightly higher 
response durations than rats treated with LPS alone, this effect is undermined by the fact 
that LPS did not produce a robust deficit. Likewise, the vehicle controls did not learn as 
well as those in previous experiments. Future work will be needed to assess whether a 
higher dose of LPS may be needed to produce a deficit, or whether a higher dose of 
TNF! inhibitor may be needed in order to see a greater difference between these two 
groups.  
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Experiment 7 
 Previous research has shown that neuronal TNF! receptor activation causes an 
increase in membrane trafficking of GluR2-lacking AMPA receptors, as well as GABA 
receptor endocytosis (Stellwagen, Beattie, Seo, & Malenka, 2005). Unlike AMPA 
receptors that express the GluR2 subunit, these receptors are calcium-permeable. This 
permeability allows for a substantial increase in postsynaptic excitability, and with 
sufficient stimulation, can lead to excitotoxicity. This phenomenon has recently been 
shown to underlie cell death following spinal cord injury (Ferguson, Christensen, et al., 
2008). Experiment 6 was designed to assess the potential role of TNF!-mediated 
upregulation of Glur2-lacking AMPA receptors in driving the overexcitation that 
underlies the spinal learning deficit. 
 
Procedure 
 Experiment 7 used 40 rats (n = 10). Twenty-four hours after complete 
transection, subjects were given an intrathecal injection of TNF" (60 pg) or vehicle in 10 
!L, followed by a 20 !l saline flush. Twenty-four hours later, subjects were given an 
intrathecal injection of the GluR2-lacking AMPA receptor antagonist Naspm or vehicle 
in 10 !L, followed by a 20 !L saline flush. All subjects were then tested for instrumental 
learning.  
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Results 
 The effect of GluR2-lacking AMPAR antagonism on the TNF"-induced deficit is 
depicted in Figure 8. As expected, those subjects that received vehicle alone were able to 
learn, while those that received TNF" alone exhibited a learning deficit. Interestingly, 
those that were given Naspm prior to testing were able to learn, regardless of whether 
they had previously been given TNF". An ANOVA revealed main effects of TNF" 
 
 
 
 
 
 
 
 
 
 
 
 
treatment and trials, Fs > 5.28, p < .01. Likewise, a significant interaction between 
TNF" and trials was observed, F (29, 1044) = 1.66, p < .05. The ANOVA did not show a 
significant three-way interaction between trials, TNF", and sTNFR1, F(29, 1044) = 1.37, 
p = .09. Because this interaction approached significance, the relationship was further 
Figure 8. Effect of Glur2-lacking AMPA receptor antagonism on the TNF"-induced 
deficit. Left panel depicts response durations over time. Right panel depicts mean response 
durations for each group, collapsed over time. Groups that received an initial injection of 
vehicle are represented by circles, those that received TNF" are shown as triangles. For the 
second injection, groups that received vehicle are shown in white, groups that received 
Naspm are shown in black. Data indicate that Naspm treatment blocks the expression of 
the TNF"-induced deficit. 
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explored using trend analyses. The trend analyses showed that the linear component of 
the Trials X TNF" X sTNFR1 interaction was significant, F = 11.89,  p < .05. Post hoc 
analysis of the group means showed that those receiving TNF" alone were significantly 
different from all other groups, p < .05. 
 
Discussion 
 This experiment showed a necessary role for calcium-permeable AMPA 
receptors in the expression of  the TNF"-induced deficit. As these receptors have 
previously been shown to mediate overexcitation and excitotoxicity, this finding lends 
evidence to the notion that the deficit induced by TNF" may reflect a saturation of spinal 
plasticity. Further, the capacity for Naspm to block the expression of the deficit provides 
a unique therapeutic potential for the reinstatement of future plasticity. 
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CHAPTER VI 
CELLULAR ASSESSMENT OF TNF! 
 Experiments 1-5 showed that pharmacological treatments that target TNF!, or its 
presumed downstream consequences, affect the capacity for spinal learning. These 
experiments suggest that the adverse effect of uncontrollable shock on instrumental 
learning is mediated by TNF!. My last two experiments used cellular assays to explore 
whether shock treatment impacts TNF! mRNA expression (Experiment 8), or protein 
levels (Experiment 9) within the spinal cord. 
 
Experiment 8 
 As Experiments 1 and 2 showed that TNF! was necessary for the expression of 
the shock-induced deficit, it is expected that uncontrollable shock would cause an 
increase in TNF! production in the spinal cord. Experiment 8 utilizes quantitative 
reverse transcriptase polymerase chain reaction (qRT-PCR) in order to assess levels of 
TNF! mRNA following controllable shock (master), uncontrollable shock (yoked), or 
no shock. As a positive control, I also assessed the expression of c-Fos, which should be 
increased by shock treatment. 
 
Procedure 
 This experiment used 24 rats (n=8). Subjects were given either master training 
(controllable shock), yoked training (uncontrollable shock) or no shock over a 30 minute 
training session. This master/yoked paradigm ensures that the amount of shock received 
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within each master/yoked pair is equal. Equating shock within pairs is important, 
because it removes the variability of timing and number of shocks received within pairs, 
so that the only variable that is being tested is whether the shock is controllable or 
uncontrollable.  
 Following training, animals were anesthetized with pentobarbital (50 mg/kg), and 
1 cm sections of L4-L5 spinal cords were removed and flash frozen at -80° C. Cord 
tissue was subsequently homogenized and prepared for RT-PCR as described in the 
general methods section.  
 
Results 
 Previous work has shown that  c-Fos expression is a reliable indicator of shock 
treatment, regardless of controllability. In order to first confirm that shock had an effect 
on the spinal tissue assayed, c-Fos expression was analyzed (Figure 9A). Both master 
and yoked groups showed an increase in c-Fos expression, and an ANOVA revealed a 
main effect of condition, F(2, 21) = 6.73, p < .05. Post hoc analysis of group means 
revealed that master and yoked groups were significantly different from unshocked 
controls, p < .05.  
 The effect of uncontrollable shock on TNF mRNA expression is depicted in 
Figure 9B. Yoked subjects that received uncontrollable shock were shown to have nearly 
a two-fold increase in TNF! mRNA expression as compared to unshocked controls. 
Though 7 of the 8 yoked rats exhibited higher TNF! mRNA expression than their 
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master partner, an overall ANOVA did not reveal any significant differences, F(2, 21) 
=1.07, p > .05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Effect of controllable and uncontrollable shock on the expression of TNF" 
mRNA. A) c-Fos mRNA expression in master, yoked, and unshocked groups. 
Upregulation of c-Fos expression was seen in both controllable (Master) and 
uncontrollable (Yoke) shock groups, as compared to unshocked controls, offering 
cellular confirmation of a shock effect. B) TNF" mRNA expression in master, 
yoked, and unshocked. Uncontrollably shocked (Yoke) subjects exhibited higher 
TNF" mRNA expression compared to master and unshocked subjects. Data 
expressed as mean fold change relative to unshocked controls. 
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Discussion 
 Reasoning that some variation was attributable to differences in early gene 
expression, we also performed an analysis of covariance, treating c-Fos expression as a 
covariate. As expected, the covariate did account for a significant proportion of the 
variance, F(1, 20) =25.83, p < .05. More importantly, the analysis yielded a significant 
effect of treatment condition, F(2, 20) = 3.65, p < .05. These results provide preliminary 
evidence that uncontrollable stimulation engages TNF! mRNA expression within the 
spinal cord.  However, while shock treatment had a robust effect on c-Fos expression, 
the observed differences in TNF! mRNA expression were less clear-cut and strongly 
linked to the level of early gene expression. Further work will be needed to clarify how 
shock treatment affects TNF! mRNA expression. 
 
Experiment 9 
 Experiment 8 examined whether uncontrollable shock upregulated TNF! 
mRNA. While this finding suggests an increase in TNF! production, it is important 
examine TNF! protein expression in order to assure that there is an increase of TNF! in 
its active form following uncontrollable shock. Experiment 9 uses an enzyme-linked 
immunosorbent assay (ELISA) to assess the time-dependent changes in TNF! protein 
levels after uncontrollable shock. 
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Procedure 
 This experiment used 36 rats (n = 6). All Subjects were given either 6 minutes of 
uncontrollable shock to the tail or an equivalent period of restraint. Because controllable 
shock appears to have no effect on TNF! mRNA expression, this simplified design was 
used rather than a master/yoked paradigm. Also, because this design used shock to the 
tail rather than the hindlimb, the absolute shock intensity and number could be kept 
constant across all shocked subjects, which should reduce the variability observed in 
mRNA/protein expression. 
 Following shock, subjects were anesthetized with pentobarbital (50 mg/kg) and 
L4-L5 spinal cord segments were taken at one of three timepoints: Immediate, 6 hr, or 
24 hr after shock administration. Cord tissue was subsequently homogenized and 
prepared for ELISA as described in the general methods section. 
 
Results 
 The effect of uncontrollable shock on TNF! protein expression is depicted in 
Figure 10. Protein levels were based upon a standard curve that was run on the same 
plate with all spinal cord samples. These values were then normalized to each sample’s 
relative total protein concentration, and this value is presented in the figure below.  
No change was seen in unshocked controls over time. In contrast, shock treatment 
appears to have produced a gradual increase in TNF! protein that emerges over time. 
Though the overall ANOVA did not yield a significant main effect or interaction, (Fs < 
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1.99, p > .05) trend analysis showed that the linear component of the interaction term 
approach significance, F (1, 30) = 3.90, p = .06. 
          To further explore the nature of this interaction, independent ANOVAs were  
performed at each time point. I found that shock had a significant impact at 24 hours  
 [F(1, 10) = 6.49, p < .05], but not at 0 or 6 hours. 
 
Discussion 
 Although no overall differences were seen between conditions, the significant 
difference between groups at 24 hours offers evidence that uncontrollable shock leads to 
long-term TNF! production, suggesting a mechanism by which uncontrollable shock 
may cause a long-term deficit.  
 Future assays may require a less dilute tissue sample in order to ensure that the 
TNF! protein levels observed are accurate. Due to the relatively insensitive nature of 
ELISA protein detection, more sensitive tests such as immunohistochemistry, may prove 
to be a better tool for investigating TNF! protein levels in the future. 
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Figure 10. Effect of uncontrollable shock on TNF" protein expression. Group means 
are shown, depicting TNF" concentrations normalized to total protein concentrations 
per subject. Unshocked groups are shown in white, shocked groups in black. Data 
indicate neither time nor shock treatment affected TNF" concentration. 
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CHAPTER VII 
GENERAL DISCUSSION AND SUMMARY 
 The experiments in this dissertation were designed to investigate the role of the 
cytokine tumor necrosis factor alpha (TNF!) in the inhibition of spinal instrumental 
learning. When assessing spinal plasticity using a spinal instrumental learning paradigm, 
we have previously found that uncontrollable stimulation produces a long-lasting 
learning deficit (Crown, et al., 2002a). This study tested whether the effect of 
uncontrollable stimulation was mediated by TNF!. Behaviorally, the learning deficit 
produced by uncontrollable shock is attenuated when endogenous TNF! is inhibited 
(Experiments 1 & 2). This effect is seen if TNF! is inhibited prior to uncontrollable 
shock, as well as if TNF! is inhibited prior to instrumental testing (24 hours after 
uncontrollable shock). Conversely, treatment with exogenous TNF! was shown to 
substitute for uncontrollable shock in eliciting a learning deficit (Experiment 3). This 
deficit was seen both immediately following and 24 hours after TNF! administration, 
and was dose-dependent.  
 The finding that exogenous TNF! produced a deficit that outlasted the initial 
drug treatment led us to investigate whether this long-term deficit was mediated by 
TNF! action, or if perhaps TNF! treatment induced a downstream neural modification 
that caused the long-term deficit. Experiment 4 showed that the long-term TNF!-
induced deficit could be attenuated by TNF! receptor inhibition, suggesting the long-
term deficit required sustained TNF receptor activity. Furthermore, the long-term effect 
of exogenous TNF! appears to be mediated by glial activation, as treatment with a glial 
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inhibitor attenuated the TNF!-induced deficit (Experiment 5). Experiment 6 tested the 
therapeutic effect of TNF! inhibition following treatment with LPS, which has been 
shown to induce TNF! release. 
 The post-synaptic effect of TNF! treatment was then assessed. TNF! has been 
shown to induce the trafficking of calcium-permeable AMPA receptors to the 
membrane, and it has been suggested that this mechanism plays a role in excitotoxicity 
and the saturation of spinal plasticity (Beattie, et al., 2002). Experiment 7 showed that 
selectively antagonizing calcium-permeable AMPA receptors prior to testing attenuated 
the long-term TNF!-induced deficit. Taken together, these findings outline a necessary 
and sufficient role for TNF! in the deleterious effect of uncontrollable stimulation, and 
suggest a critical role for TNF! in undermining adaptive spinal plasticity. Finally, I 
showed that uncontrollable shock can produce an upregulation of TNF! mRNA 
expression in the spinal cord (Experiment 8).  
 
TNF! and the Deficit: Links to Central Sensitization 
 Work over the past decade has shown TNF! to be an important factor in glial-
neuronal interactions. The capacity to induce changes in synaptic strength has made 
TNF! an attractive target as a potential mediator of synaptic plasticity (reviewed in 
Pickering, Cumiskey, & O’Connor, 2005; Park & Bowers, 2010). Stellwagen and 
Malenka (2006) outlined a constitutive role for TNF! in the global scaling of synaptic 
populations. They have shown that in response to a drop in neural activity, glial release 
of TNF! leads to an increase in excitation, which in turn brings the neural environment 
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back to homeostatic levels. Although this finding describes TNF! as being critical to 
regulating synaptic efficacy, homeostasis is a delicate balancing act. While appropriate 
levels of TNF! can act to normalize neurotransmission, overexpression of TNF! can 
lead to synaptic dysfunction. A number of studies have shown that the overexpression of 
TNF! (due either to pharmacological manipulation or pathological induction) can lead 
to excitotoxicity and disruption in plasticity (Hermann, Rogers, Bresnahan, & Beattie, 
2001; Butler, O’Connor, & Moynagh, 2004). In slice preparations of both the CA1 and 
dentate gyrus regions of the hippocampus, bath application of pathophysiological levels 
of TNF! led to the inhibition of long-term potentiation, a form of synaptic plasticity 
believed to underlie learning and memory in these brain regions (Tancredi, et al., 1992; 
Cunningham, Murray, O’Neill, Lynch, O’Connor, 1996; Bliss & Collingridge, 1993). In 
vivo studies have confirmed these findings, showing that mice in which TNF! is 
overexpressed exhibit marked impairment in spatial learning using a water maze task 
(Aloe, et al., 1999).  
 Interestingly, high levels of TNF! in the spinal cord produce different effects 
than in the hippocampus. As opposed to inhibiting LTP in the hippocampus, 
overexpression of TNF! in dorsal horn neurons induces LTP (Liu, et al., 2007). This 
increase in excitatory synaptic strength has been most commonly found in primary 
afferents, which carry nociceptive sensory information (Sorkin, Xiao, Wagner, & Myers, 
1997). Synaptic potentiation in the dorsal horn has been termed central sensitization, and 
has been suggested to be a mechanism for neuropathic pain (reviewed in Latremoliere & 
Woolf, 2009). Inducing central sensitization through a number of inflammatory models 
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has been shown to produce a marked increase in the expression of TNF! in both the 
peripheral and central nervous systems (Schafers, Geis, Svensson, Luo, & Sommer, 
2003; Bao, Zhu, Elhassan, Wu, Xiao, & Zhu, 2001). TNF! has also been shown to 
induce behavioral symptoms of neuropathic pain (including allodynia and hyperalgesia) 
when given exogenously (Gao, et al., 2009; Youn, Wang, & Jeong, 2008). Conversely, 
inhibition of TNF! activity through genetic knockout of TNF! production and/or TNF! 
receptor antagonists have proven therapeutic against neuropathic pain (Mata, Hao, & 
Fink, 2008; Sommer, Schafers, Marziniak, & Toyka, 2001). Findings such as these have 
led many to consider TNF! an important mediator of enhanced nociceptive processing 
in the spinal cord, and have provided further evidence that TNF! contributes to 
maladaptive spinal plasticity (reviewed in Leung & Cahill, 2010). 
 Previous work from our lab has also implicated the kappa opioid system in the 
deficit produced by uncontrollable shock, showing a necessary and sufficient role of 
kappa opioid receptor activity in the spinal learning deficit (Joynes & Grau, 2004; 
Washburn, et al., 2008). Interestingly, kappa opioid receptor activation has also been 
shown to act on astrocytes to increase intracellular calcium concentrations, and could 
potentially lead to increased glial activation and TNF! release (Gurwell, et al., 1996; 
Stiene-Martin, Mattson, & Hauser, 1993; Shafer & Murphy, 1997). Further, others have 
shown direct immunomodulatory effects of kappa opioid ligands, as the endogenous 
opioid dynorphin has been shown to increase TNF! expression in the brain (Chao, et al., 
1995). Because both TNF! and kappa opioid receptors have been shown to be essential 
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to the expression of the spinal learning deficit, there may be an important interaction 
between these systems that will need to be investigated in the future. 
  More recent findings from our lab have drawn a link between central 
sensitization and the spinal learning deficit, suggesting that uncontrollable stimulation 
induces a central sensitization-like effect in the spinal cord which undermines future 
learning (Ferguson, et al., 2006; Hook, Huie, & Grau, 2008).  Experiments 1 and 2 
showed that the deficit produced by uncontrollable shock requires TNF!. These findings 
mirror those that have shown TNF! to be necessary in the development of neuropathic 
pain. From this perspective, TNF! can be seen as an important neurobiological mediator 
by which uncontrollable shock undermines spinal learning, and provides further 
evidence that the deficit may reflect a change in synaptic strength that is akin to central 
sensitization.  
 
Mechanisms of Action 
 The experiments in this dissertation provide evidence that the learning deficit 
produced by uncontrollable shock depends on TNF!. The following section will address 
the possible mechanisms by which 1) uncontrollable stimulation leads to TNF! 
production and release, 2) TNF! affects post-synaptic neurons to undermine spinal 
learning 3) TNF! mediates the long-term deficit. 
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Shock-Induced Production and Release of TNF! 
 Experiment 8 showed that uncontrollable peripheral shock can cause an 
upregulation of TNF! mRNA expression in the region of the spinal cord that is essential 
for instrumental learning. Given that uncontrollable shock has been previously shown to 
induce a central sensitization-like effect, these findings are not surprising. The role for 
TNF! in mediating inflammatory processes in the spinal cord has been well-defined. If 
we are to think of uncontrollable shock as working in a similar manner to other models 
of peripheral inflammation, then a central increase in TNF! production and release is to 
be expected. Intraplantar injection of inflammatory agents such as carrageenan and 
capsaicin induce robust increases in spinal TNF! levels, as do models of peripheral 
nerve injury including chronic constriction injury and spinal nerve ligation (DeLeo, 
Colburn, & Rickman, 1997; Schafers, Svensson, Sommer, & Sorkin, 2003). Following 
peripheral insult, a barrage of excitatory signaling from Aß and C fibers reaches primary 
afferents in the dorsal horn of the spinal cord. This heightened excitatory input sensitizes 
central neurons, leading to secondary hyperalgesia and ultimately the development of 
chronic neuropathic pain states. As the study of this phenomenon has grown, TNF! has 
emerged as a critical inflammatory mediator in both the peripheral and central nervous 
system. Inhibition of TNF! activity following peripheral nerve injury has been shown to 
alleviate injury-induced hyperalgesia (Sommer, Schafers, Marziniak, & Toyka, 2001). 
Likewise, inhibiting TNF! prior to peripheral injury provides a protection against the 
development of mechanical allodynia (Schafers, Svensson, Sommer, & Sorkin, 2003). 
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 How might inflammatory signaling from the periphery (like uncontrollable 
shock) induce TNF! release in the CNS? The answer appears to lie in the activation of 
microglia and astrocytes. In response to nociceptive input, primary afferents innervating 
the spinal dorsal horn release neuromodulatory transmitters, including glutamate and 
substance P, and induce the release of adenosine triphosphate (ATP) and fractalkine 
from secondary spinal neurons (Moalem & Tracey, 2006). Fractalkine and ATP bind to 
the CXCR1 and P2X4 receptors, respectively, which are found on the glia surrounding 
neurons in the spinal cord. Activation of these receptors, as well as the substance P 
receptor NK1, induces a critical physiological and morphological change in microglia 
and astrocytes. Normally in a relatively quiescent, ramified state, receptor activity on the 
cell surface produces a shift to an amoeboid shape and sets in motion a flurry of 
intracellular activity, including the mobilization of intracellular calcium stores and 
downstream second messenger signaling (Watkins, Milligan, & Maier, 2001). Among 
the signaling cascade, mitogen-activated protein kinase p38 (p38 MAPK) has been 
shown to be essential (Tsuda, Mizokoshi, Shigemoto-Mogami, Koizumi, Inoue, 2004; 
Svensson, Schafers, Jones, Powell, & Sorkin, 2005). Activation of p38 leads to gene 
transcription that regulates the secretion of a number cytokines, including IL-1", IL-6, 
and importantly, TNF! (Ji & Suter, 2007).  
 Given that uncontrollable shock has been shown to engage nociceptive pathways 
and induce central sensitization-like effects, it is likely that the shock-induced 
upregulation of TNF! mRNA observed in Experiment 8 is due to release from activated 
glia. This notion is further strengthened by the recent finding showing glial activation to 
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be necessary in order for uncontrollable shock to produce a spinal learning deficit 
(Vichaya, et al., 2009). Further work will be needed in order to confirm that shock-
induced TNF! production and release is mediated by p38 MAPK. Although others have 
shown that inhibiting p38 in activated microglia attenuates TNF! expression, this work 
was done in microglial cell cultures (Bhat, Zhang, Lee, & Hogan, 1998). The difficulty 
in elucidating the role of microglial p38 in an in vivo model of spinal plasticity lies in the 
fact that p38 MAPK is also critical to neuronal function. Thus, a broad p38 MAPK 
inhibitor would alter both glial and neuronal p38 MAPK function.  
 
TNF! Saturates Synaptic Plasticity 
 As discussed previously, the spinal learning deficit produced by uncontrollable 
shock is believed to reflect a form of overexcitation that saturates future plasticity. We 
have shown that uncontrollable shock produces an increase in TNF! mRNA expression 
(Experiment 8), and that TNF! is both necessary and sufficient to produce the deficit 
(Experiments 1-4). Further, we have also reviewed evidence for the role of TNF! in 
sensitizing spinal neurons. Together, these lines of evidence suggest that TNF! may 
mediate the shock-induced deficit. The following section will discuss the specific role of 
TNF! in modulating synaptic strength and provide a possible mechanism by which 
TNF! might elicit a saturation effect that undermines learning. 
 TNF! receptor (TNFR1) activation has been shown to increase neural 
excitability by directly, and indirectly, affecting ion channels through a number of 
distinct intracellular pathways. Using cultured hippocampal slices, Furukawa and 
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Mattson (1998) observed a significant increase in current through L-type calcium 
channels following long-term incubation with TNF!. This effect was dependent upon 
TNFR1 activation of the downstream transcription factor nuclear factor-kappa B (NF-
kB). TNF! application has also been shown to rapidly enhance currents in tetrodotoxin-
resistant Na+ channels, leading to acute mechanical sensitization (X. Jin & Gereau, 
2006). Interestingly, this effect was mediated by a TNFR1-dependent phosphorylation of 
p38 MAPK. Coupled with the necessity for this kinase in the glial release of TNF!, this 
finding suggests a critical role for p38 MAPK in both the neural and glial effects of 
TNF!. 
 Despite having some direct effects on excitability through ion channels, TNF! 
has been more widely characterized by its capacity to indirectly affect synaptic strength 
by modulating glutamatergic neurotransmission. TNF! has been shown to induce an 
increase in the surface localization and phosphorylation of the NMDA receptor subunit 
NR1 (Wheeler et al., 2009). The phosphorylation of this subunit has been suggested as a 
mechanism by which NMDA receptor trafficking occurs (Swope, Moss, Raymond, 
Huganir, 1999). Furthermore, brief application of TNF! in this preparation was shown 
to increase NMDA-evoked calcium currents (Wheeler, et al., 2009). To date, an in vivo 
behavioral correlate for this effect has not been investigated. 
 In 2002, Beattie and colleagues demonstrated that glial TNF! act upon neuronal 
TNFR1 to increase trafficking of AMPA receptors to the post-synaptic membrane. 
Importantly, the AMPA receptors that were expressed were found to be lacking the 
GluR2 subunit, which normally prohibits the influx of calcium. As such, the TNF!-
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induced AMPA receptor trafficking led to a increase in neuronal excitability. Stellwagen 
refined the view of this phenomenon by illustrating that TNFR1 acts upon the 
phosphotidylinositol 3-kinase (PI3) pathway to mediate the trafficking of calcium 
permeable AMPA receptors (Stellwagen & Malenka, 2006). Further, this effect has been 
recently shown to undermine neural function following spinal cord injury (Ferguson, et 
al., 2008). It was the well-defined nature of this effect that led us to hypothesize that 
TNF! saturates spinal plasticity through the increase in surface expression of calcium-
permeable AMPA receptors. Experiment 6 showed that the selective inhibition of these 
AMPA receptors attenuates the TNF!-induced deficit. This finding provides substantial 
evidence for the possibility that this pathway mediates the detrimental effects of TNF! 
on spinal plasticity.  
 
Glial TNF and the Long-Term Deficit 
 Experiment 3 showed that intrathecal TNF! treatment is sufficient to produce a 
spinal learning deficit when given immediately prior to testing, and interestingly, 24 
hours prior to testing. This finding led me to investigate the mechanism by which this 
long-term effect of TNF! occurs. As discussed above, TNF! can engage a number of 
excitatory pathways that could be responsible for the long-term deficit. Surprisingly, I 
found in Experiment 4 that inhibiting TNF! receptor activity prior to testing blocked the 
long-term TNF!-induced deficit. This finding suggests that sustained TNF! receptor 
activity is necessary in order for the deficit to be expressed. From this perspective, 
TNF! can be thought to act in one of two ways: either the exogenous TNF! is 
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continuing to activate TNF receptors 24 hours after administration, or the administered 
TNF! is keeping receptors active by inducing the release of further endogenous TNF! 
stores. While acute TNF administration has not been shown to directly elicit sustained 
TNF receptor activation, the capacity for TNF! to stimulate the production and release 
of more TNF! has been well defined (reviewed in Ji & Suter, 2007; Kuno, et al., 2005). 
As stated before, TNF! is primarily produced by, and released from, astrocytes and 
microglia. Among the numerous receptors found on these glial cells are TNF! receptors. 
Thus, TNF! released from glial cells has the opportunity to bind to the same cell from 
which it came. Much like the ATP-binding P2X4 receptors, glial TNF receptors activate 
p38 MAPK pathway, inducing gene transcription and ultimately, the release of further 
TNF!. This autocrine function of TNF! produces a feed-forward loop in which TNF! 
protein levels, and corresponding neuronal TNF receptor activity, can be sustained for 
long periods of time (Yarilina, Park-Min, Antoniv, Hu, & Ivashkiv, 2008). This 
recursive pattern has been implicated as a mechanism for the perpetuation of 
inflammatory pain states (Kuno, et al., 2005).  
 In order for this effect to occur, a complex signaling cascade within glia must be 
engaged. Thus, if the long-term TNF!-induced deficit is mediated by such a mechanism, 
glial metabolism would be essential. In Experiment 5, we tested the necessity for glial 
metabolism by administering fluorocitrate, a glial inhibitor, prior to TNF treatment. We 
found that in order for TNF to produce a long-term deficit, glial metabolism was 
essential. Similarly, prior work showed fluorocitrate to block the long-term deficit 
induced by uncontrollable shock (Vichaya, et al., 2009). The convergence of these 
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findings provides an attractive link between uncontrollable shock, TNF! expression, and 
the long-term inhibition of adaptive spinal plasticity.  
 
The Role of TNF! in the Deficit: A Molecular Model 
 When the results of the previous experiments are taken together, a  
comprehensive role of TNF! in undermining spinal plasticity begins to emerge. Figure 
11 depicts a potential model of the way in which uncontrollable stimulation induces 
TNF! expression and the subsequent effects of TNF! on synaptic plasticity.  Included in 
this model are the intracellular mechanisms for glial production of TNF! and the post-
synaptic effects of TNF! on non-AMPA ion channels. Although these effects were not 
directly tested in the current experiments, a large body of work showing their importance 
in synaptic function suggests their possible involvement in the TNF!-induced deficit 
(Park & Bowers, 2010). This model is careful to remain neutral in the depiction of an 
activated glial cell, without choosing between microglia and astrocytes. Both cell types 
have been shown to produce and release TNF! upon activation (Lieberman, Pitha, Shin, 
& Shin, 1989; Chao, et al., 1992). Likewise, both astrocytes and microglia have been 
suggested to potentiate further cytokine release through autocrine mechanisms (Ji & 
Suter, 2007; Phulwani, Esen, Syed, & Kielian, 2008). Interestingly, others have also 
highlighted the importance of cross-talk between these cells, showing that the release of 
TNF! by activated astrocytes can be facilitated by concomitant microglial activation 
(Bezzi, et al., 2001). Therefore, it is unlikely that the role of glia in the TNF!-induced 
deficit is circumscribed to microglia or astrocytes alone.  
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 Experiment 7 showed that GluR2-lacking AMPA receptors were necessary for 
the expression of the long-term TNF!-induced deficit, but their sufficiency in this effect 
is yet to be determined. As discussed previously, it is likely that TNF! engages a 
number of excitatory pathways, and thus the expression of the deficit may reflect a 
summation of these effects. A similar theory of the additive effect of TNF! has been 
proposed by Cumiskey and colleagues. They have shown inhibition of metabotropic 
glutamate receptors (mGluR) attenuates TNF!-induced impairment of LTP, and have 
suggested that the combined action of TNF! receptors and mGlu receptors on the p38 
pathway is sufficient to increase intracellular calcium to a level that impairs plasticity 
(Cumiskey, Butler, Moynagh, & O’ Connor, 2007; Pickering, Cumiskey, & O’Connor, 
2005). This finding is especially interesting in light of the recent data showing a critical 
role for mGlu receptor activation in the spinal learning deficit induced by uncontrollable 
shock (Ferguson, Bolding, et al., 2008).  
  This model presents a simplification of a complex system, providing a 
representation of the key components of the system, rather than an exhaustive detailing 
of the intricacies therein. The model highlights the findings from the current 
experiments, while providing speculative connections based on work from other 
preparations. Further experiments will be necessary to test the extent to which these 
pathways are involved in the TNF!-induced deficit.  
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Figure 11. A model of the role of TNF! in the deficit. Following uncontrollable shock, a number 
of signaling molecules are released in the spinal cord, including fractalkine and ATP. These 
molecules bind to receptors on glia, causing an influx of calcium and the activation of the p38 
MAPK pathway. This pathway engages gene transcription factors that mediate the production 
and release of TNF!. Once TNF! is released, it can bind to TNF receptors on the same cell from 
which it was released. This autocrine function leads back through the p38 MAPK pathway to 
induce further TNF! production and release. Post synaptically, TNF! binds to the TNFR1 
receptor, which engages a number of distinct excitatory pathways, increasing trafficking of 
NMDA and AMPA receptors. It is proposed that the hyperexcitable state induced by sustained 
TNF! activity saturates plasticity, undermining future learning.  
 
 
Clinical Implications 
 At normal physiological levels, TNF! has been shown to play an important role 
in regulating synaptic homeostasis. It is in response to neural insult or immune challenge 
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that TNF! overexpression can occur, causing an inflammatory response that may 
undermine proper neural functioning. The deleterious effect of TNF! can be seen in a 
number of pathologies in both the brain and spinal cord. Increased expression of TNF! 
has been shown in patients with Parkinson’s disease, as well as in mouse models of 
Alzheimer’s disease (Mogi, et al., 1994; Janelsins, et al., 2008). Although some have 
shown the link between TNF! in these diseases to be correlative, others have shown 
some direct effects of TNF! on the progression of the disease. Alzheimer’s disease is 
characterized by the production of plaques that are believed to be derived from the 
expression of the peptide amyloid-beta (Aß). Administration of TNF! has been shown to 
increase the production of Aß (Luo, Wang, Cheng, Kuo, & Wolfe, 2004; Li, et al., 
2004). Aß then stimulates the activation of microglia, leading to further TNF! release (J. 
J. Jin, Kim, Maxwell, Li, & Fukuchi, 2008). This feed-forward loop has been recently 
suggested to underlie the pathogenesis of the disease (Park & Bowers, 2010). As this 
mechanism is similar to the one proposed for the shock-induced increase in TNF! 
illustrated above, future work to determine the pathways involved in our model may 
have implications for the development of Alzheimer’s disease. 
 Experiments 1, 2 and 4 showed that the inhibition of TNF! attenuates the 
deleterious effects of uncontrollable shock as well as prior TNF! exposure. Although 
designed primarily to test the necessity of TNF! receptor activity in the spinal learning 
deficit, these findings also outlined a role for TNF! inhibition as a therapeutic 
intervention. The inhibition of TNF! has recently gained attention as an important tool 
in fighting a number of inflammatory processes, and a TNF! inhibitors (infliximab, 
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etanercept, and adalimumab Humira) are currently indicated for the treatment of arthritis 
and psoriasis (Tobin & Kirby, 2005). Further research is expanding the role of TNF! 
inhibition as a therapy, as it has been shown that selectively ablating TNF! receptors can 
attenuate dopaminergic neurotoxicity, a major neural consequence believed to underlie 
the development of Parkinson’s disease (Sriram, et al., 2002; McCoy, et al., 2006). 
Inhibition of TNF! receptor activity using the soluble TNFR1 has also shown promise in 
the fight against secondary damage following spinal cord injury. Ferguson and 
colleagues showed that inhibition of TNF! activity significantly reduced the trafficking 
of calcium-permeable AMPA receptors and attenuated subsequent excitotoxic cell death 
in the spinal cord (Ferguson, et al., 2008).   
  
Summary and Future Directions 
 The experiments in this dissertation were designed to determine the role of TNF! 
in the spinal learning deficit. Cellular assays showed uncontrollable shock to increase 
TNF! mRNA expression in the spinal cord. Behavioral findings showed TNF! to be 
necessary in order for uncontrollable shock to produce a deficit, and to be sufficient to 
produce a deficit in lieu of shock treatment. The TNF!-induced deficit was shown to be 
long-lasting, and this long-term deficit required glial activation at the time of induction, 
as well as TNF receptor activation at the time of expression. Finally, the post-synaptic 
effects of TNF! were investigated, and the TNF!-induced expression of calcium-
permeable AMPA receptors was shown to be necessary for the expression of the long-
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term deficit. Together, these findings suggest a critical role for TNF! in producing an 
excitatory neural environment that saturates plasticity and undermines spinal learning.  
 In contrast to the deleterious effects of TNF! on spinal learning, a recent set of 
experiments has outlined a necessary and sufficient role for brain-derived neurotrophic 
factor (BDNF) in mediating the beneficial effects of spinal instrumental training (Huie, 
et al., 2007). Rather than induce a learning deficit, BDNF treatment can protect against 
the deleterious effects of uncontrollable shock, as well as rescue learning after the deficit 
has been induced. Interestingly, TNF! and BDNF have been shown to play opposite 
roles in synaptic scaling (Turrigiano, 2008). The opposing effects of these two agents 
suggests a possible constitutive balance between TNF! and BDNF, and tipping one or 
the other toward overexpression may be key in shifting spinal metaplasticity between 
adaptive and maladaptive outcomes. Future work will be needed to understand the 
dynamic between TNF! and BDNF. For example, can BDNF rescue the learning after 
the deficit has been induced by TNF!? 
 Other work has shown GABA receptor activation to be necessary and sufficient  
to produce a spinal learning deficit (Ferguson,  et al., 2003). Interestingly, an increase in 
GABA receptors exocytosis has been observed following spinal cord injury (Ferguson, 
personal communication).  Because injury has also been shown to increase TNF! levels, 
and both TNF and GABA have been shown to mediate the spinal learning deficit, there 
may be a critical interaction between these systems that will need to be investigated. If 
TNF! induces an increase in GABA receptor activity that contributes to the deficit, then 
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it would be of interest to determine whether treatment with a GABA antagonist could 
block the expression of the TNF!-induced deficit. 
 Future work will also be needed in order to fully elucidate the cellular 
mechanisms through which TNF! works to undermine spinal plasticity. Histological 
imaging of the colocalization of TNF! protein with microglia and astrocytes will 
provide much-needed information as to the relative roles of each cell type. Further, 
attention will need to be focused on intracellular signaling pathways, including p38 
MAPK, NF-kB, and PI3 with the aim of identifying the potential mediators of TNF! 
overexpression and synaptic saturation. In understanding the role of TNF! in 
maladaptive spinal functioning, we can derive therapeutic potential and work to prevent 
or reverse these processes, reinstating a neural environment that is once again receptive 
to adaptive plasticity. 
 
 
 
 
 
 
 
 
 
 
 68 
 REFERENCES 
 Albensi, B. C., & Mattson, M. P. (2000). Evidence for the involvement of TNF and NF-
kappaB in hippocampal synaptic plasticity. Synapse, 35(2), 151-159. 
Aloe, L., Properzi, F., Probert, L., Akassoglou, K., Kassiotis, G., Micera, A., et al. 
(1999). Learning abilities, NGF and BDNF brain levels in two lines of TNF-
alpha transgenic mice, one characterized by neurological disorders, the other 
phenotypically normal. Brain Res, 840(1-2), 125-137. 
Bao, L., Zhu, Y., Elhassan, A. M., Wu, Q., Xiao, B., Zhu, J., et al. (2001). Adjuvant-
induced arthritis: IL-1 beta, IL-6 and TNF-alpha are up-regulated in the spinal 
cord. Neuroreport, 12(18), 3905-3908. 
Baumbauer, K. M., Young, E. E., Hoy, K. C., Jr., & Joynes, R. L. (2007). Intrathecal 
administration of neurokinin 1 and neurokinin 2 receptor antagonists undermines 
the savings effect in spinal rats seen in an instrumental learning paradigm. Behav 
Neurosci, 121(1), 186-199. 
Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow, 
M., et al. (2002). Control of synaptic strength by glial TNFalpha. Science, 
295(5563), 2282-2285. 
Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., et al. (2001). 
CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by 
microglia triggers neurotoxicity. Nat Neurosci, 4(7), 702-710. 
Bhat, N. R., Zhang, P., Lee, J. C., & Hogan, E. L. (1998). Extracellular signal-regulated 
kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible 
 69 
nitric oxide synthase and tumor necrosis factor-alpha gene expression in 
endotoxin-stimulated primary glial cultures. J Neurosci, 18(5), 1633-1641. 
Bliss, T. V., & Collingridge, G. L. (1993). A synaptic model of memory: long-term 
potentiation in the hippocampus. Nature, 361(6407), 31-39. 
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994). 
Immunocytochemical analysis of tumor necrosis factor and its receptors in 
Parkinson's disease. Neurosci Lett, 172(1-2), 151-154. 
Butler, M. P., O'Connor, J. J., & Moynagh, P. N. (2004). Dissection of tumor-necrosis 
factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-
activated protein kinase-dependent mechanism which maps to early-but not late-
phase LTP. Neuroscience, 124(2), 319-326. 
Chao, C. C., Gekker, G., Sheng, W. S., Hu, S., Portoghese, P. S., & Peterson, P. K. 
(1995). Endogenous opioid peptides suppress cytokine-mediated upregulation of 
HIV-1 expression in the chronically infected promonocyte clone U1. Adv Exp 
Med Biol, 373, 65-72. 
Chao, C. C., Hu, S., Close, K., Choi, C. S., Molitor, T. W., Novick, W. J., et al. (1992). 
Cytokine release from microglia: differential inhibition by pentoxifylline and 
dexamethasone. J Infect Dis, 166(4), 847-853. 
Chen, G., & Goeddel, D. V. (2002). TNF-R1 signaling: a beautiful pathway. Science, 
296(5573), 1634-1635. 
Choi, J. I., Svensson, C. I., Koehrn, F. J., Bhuskute, A., & Sorkin, L. S. (2006). 
Peripheral inflammation induces tumor necrosis factor dependent AMPA 
 70 
receptor trafficking and Akt phosphorylation in spinal cord in addition to pain 
behavior. Pain, 149(2), 243-253.  
Chopin, S. F., & Bennett, M. H. (1975). The effect of unavoidable shock on instrumental 
avoidance conditioning in spinal rats. Physiol Behav, 14(04), 399-401. 
Chopin, S. F., & Buerger, A. A. (1975). Graded acquisition of an instrumental avoidance 
response by the spinal rat. Physiol Behav, 15(2), 155-158. 
Church, R. M. & Lerner, N. D. (1976). Does the headless roach learn to avoid? 
 Physiological Psychology, 4, 439-442. 
Cocchiara, R., Lampiasi, N., Albeggiani, G., Bongiovanni, A., Azzolina, A., & Geraci, 
D. (1999). Mast cell production of TNF-alpha induced by substance P evidence 
for a modulatory role of substance P-antagonists. J Neuroimmunol, 101(2), 128-
136. 
Crown, E. D., Ferguson, A. R., Joynes, R. L., & Grau, J. W. (2002a). Instrumental 
learning within the spinal cord: IV. Induction and retention of the behavioral 
deficit observed after noncontingent shock. Behav Neurosci, 116(6), 1032-1051. 
Crown, E. D., Ferguson, A. R., Joynes, R. L., & Grau, J. W. (2002b). Instrumental 
learning within the spinal cord. II. Evidence for central mediation. Physiol 
Behav, 77(2-3), 259-267. 
Cumiskey, D., Butler, M. P., Moynagh, P. N., & O'Connor J, J. (2007). Evidence for a 
role for the group I metabotropic glutamate receptor in the inhibitory effect of 
tumor necrosis factor-alpha on long-term potentiation. Brain Res, 1136(1), 13-19. 
Cunningham, A. J., Murray, C. A., O'Neill, L. A., Lynch, M. A., & O'Connor, J. J. 
(1996). Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit 
 71 
long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett, 203(1), 17-
20. 
Czeschik, J. C., Hagenacker, T., Schafers, M., & Busselberg, D. (2008). TNF-alpha 
differentially modulates ion channels of nociceptive neurons. Neurosci Lett, 
434(3), 293-298. 
de Leon, R. D., Hodgson, J. A., Roy, R. R., & Edgerton, V. R. (1998). Locomotor 
capacity attributable to step training versus spontaneous recovery after 
spinalization in adult cats. J Neurophysiol, 79(3), 1329-1340. 
DeLeo, J. A., Colburn, R. W., & Rickman, A. J. (1997). Cytokine and growth factor 
immunohistochemical spinal profiles in two animal models of mononeuropathy. 
Brain Res, 759(1), 50-57. 
Elliott, M. B., Barr, A. E., Clark, B. D., Amin, M., Amin, S., & Barbe, M. F. (2009). 
High force reaching task induces widespread inflammation, increased spinal cord 
neurochemicals and neuropathic pain. Neuroscience, 158(2), 922-931. 
Ferguson, A. R., Bolding, K. A., Huie, J. R., Hook, M. A., Santillano, D. R., Miranda, R. 
C., et al. (2008). Group I metabotropic glutamate receptors control metaplasticity 
of spinal cord learning through a protein kinase C-dependent mechanism. J 
Neurosci, 28(46), 11939-11949. 
Ferguson, A. R., Christensen, R. N., Gensel, J. C., Miller, B. A., Sun, F., Beattie, E. C., 
et al. (2008). Cell death after spinal cord injury is exacerbated by rapid TNF 
alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J 
Neurosci, 28(44), 11391-11400. 
 72 
Ferguson, A. R., Crown, E. D., & Grau, J. W. (2006). Nociceptive plasticity inhibits 
adaptive learning in the spinal cord. Neuroscience, 141(1), 421-431. 
Ferguson, A. R., Washburn, S. N., Crown, E. D., & Grau, J. W. (2003). GABA(A) 
receptor activation is involved in noncontingent shock inhibition of instrumental 
conditioning in spinal rats. Behav Neurosci, 117(4), 799-812. 
Fitzgerald, L. A., & Thompson, R. F. (1967). Classical conditioning of the hindlimb 
 flexion reflex in the acute spinal cat. Psychonomic Science, 8, 
 213-214. 
Forssberg, H., Grillner, S., & Rossignol, S. (1975). Phase dependent reflex reversal 
during walking in chronic spinal cats. Brain Res, 85(1), 103-107. 
Fouad, K., & Tse, A. (2008). Adaptive changes in the injured spinal cord and their role 
in promoting functional recovery. Neurol Res, 30(1), 17-27. 
Furukawa, K., & Mattson, M. P. (1998). The transcription factor NF-kappaB mediates 
increases in calcium currents and decreases in NMDA- and AMPA/kainate-
induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. 
J Neurochem, 70(5), 1876-1886. 
Galan, A., Laird, J. M., & Cervero, F. (2004). In vivo recruitment by painful stimuli of 
AMPA receptor subunits to the plasma membrane of spinal cord neurons. Pain, 
112(3), 315-323. 
Gao, Y. J., Zhang, L., Samad, O. A., Suter, M. R., Yasuhiko, K., Xu, Z. Z., et al. (2009). 
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central 
sensitization and neuropathic pain. J Neurosci, 29(13), 4096-4108. 
 73 
Golan, H., Levav, T., Mendelsohn, A., & Huleihel, M. (2004). Involvement of tumor 
necrosis factor alpha in hippocampal development and function. Cereb Cortex, 
14(1), 97-105. 
Grau, J. W., Barstow, D. G., & Joynes, R. L. (1998). Instrumental learning within the 
spinal cord: I. Behavioral properties. Behav Neurosci, 112(6), 1366-1386. 
Grau, J. W., Crown, E. D., Ferguson, A. R., Washburn, S. N., Hook, M. A., & Miranda, 
R. C. (2006). Instrumental learning within the spinal cord: underlying 
mechanisms and implications for recovery after injury. Behav Cogn Neurosci 
Rev, 5(4), 191-239. 
Grau, J. W., & Hook, M. A. (2006). Spinal neurons exhibit a surprising capacity to learn 
and a hidden vulnerability when freed from the brain's control. Curr Neurol 
Neurosci Rep, 6(3), 177-180. 
Grau, J. W., Washburn, S. N., Hook, M. A., Ferguson, A. R., Crown, E. D., Garcia, G., 
et al. (2004). Uncontrollable stimulation undermines recovery after spinal cord 
injury. J Neurotrauma, 21(12), 1795-1817. 
Gurwell, J. A., Duncan, M. J., Maderspach, K., Stiene-Martin, A., Elde, R. P., & Hauser, 
K. F. (1996). kappa-opioid receptor expression defines a phenotypically distinct 
subpopulation of astroglia: relationship to Ca2+ mobilization, development, and 
the antiproliferative effect of opioids. Brain Res, 737(1-2), 175-187. 
Hallenbeck, J. M. (2002). The many faces of tumor necrosis factor in stroke. Nat Med, 
8(12), 1363-1368. 
 74 
Hermann, G. E., Rogers, R. C., Bresnahan, J. C., & Beattie, M. S. (2001). Tumor 
necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated 
cell death in the rat spinal cord. Neurobiol Dis, 8(4), 590-599. 
Hollmann, M., Hartley, M., & Heinemann, S. (1991). Ca2+ permeability of KA-AMPA-
-gated glutamate receptor channels depends on subunit composition. Science, 
252(5007), 851-853. 
Hook, M. A., Huie, J. R., & Grau, J. W. (2008). Peripheral inflammation undermines the 
plasticity of the isolated spinal cord. Behav Neurosci, 122(1), 233-249. 
Hoy, K.C., Huie, J.R., Grau, J.W. (2006). Administration of the AMPA antagonist 
 CNQX disrupts instrumental learning, and the induction of a learning deficit, in 
 spinally transected rats. 2006 Abstract Viewer/Itinerary Planner. Washington, 
 DC: Society for Neuroscience. Online. 
Hoy, K. C., Huie, J. R., Baumbauer, K. M., & Grau, J. W. (2007) Administration of 
AMPA-receptor agonist AMPA disrupts instrumental learning in spinally 
transected rats. 2007 Neuroscience Meeting Planner. Washington, DC: Society 
for Neuroscience. Online. 
Huie, J. R., Hoy, K. C., Miranda, R. A., & Grau, J. W. (2007). Instrumental learning in 
the spinalized rat: A therapeutic effect of BDNF. Neuroscience Meeting Planner. 
Washington, DC: Society for Neuroscience, 2007. Online. 
Hwang, H. J., Lee, H. J., Kim, C. J., Shim, I., & Hahm, D. H. (2008). Inhibitory effect of 
amygdalin on lipopolysaccharide-inducible TNF-alpha and IL-1beta mRNA 
 75 
expression and carrageenan-induced rat arthritis. J Microbiol Biotechnol, 18(10), 
1641-1647. 
Ihnatko, R., & Kubes, M. (2007). TNF signaling: early events and phosphorylation. Gen 
Physiol Biophys, 26(3), 159-167. 
Janelsins, M. C., Mastrangelo, M. A., Park, K. M., Sudol, K. L., Narrow, W. C., Oddo, 
S., et al. (2008). Chronic neuron-specific tumor necrosis factor-alpha expression 
enhances the local inflammatory environment ultimately leading to neuronal 
death in 3xTg-AD mice. Am J Pathol, 173(6), 1768-1782. 
Ji, R. R., & Suter, M. R. (2007). p38 MAPK, microglial signaling, and neuropathic pain. 
Mol Pain, 3, 33-42. 
Jin, J. J., Kim, H. D., Maxwell, J. A., Li, L., & Fukuchi, K. (2008). Toll-like receptor 4-
dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's 
disease. J Neuroinflammation, 5, 23-33. 
Jin, X., & Gereau, R. W. t. (2006). Acute p38-mediated modulation of tetrodotoxin-
resistant sodium channels in mouse sensory neurons by tumor necrosis factor-
alpha. J Neurosci, 26(1), 246-255. 
Joynes, R. L., Ferguson, A. R., Crown, E. D., Patton, B. C., & Grau, J. W. (2003). 
Instrumental learning within the spinal cord: V. Evidence the behavioral deficit 
observed after noncontingent nociceptive stimulation reflects an intraspinal 
modification. Behav Brain Res, 141(2), 159-170. 
 76 
Joynes, R. L., & Grau, J. W. (2004). Instrumental learning within the spinal cord: III. 
Prior exposure to noncontingent shock induces a behavioral deficit that is 
blocked by an opioid antagonist. Neurobiol Learn Mem, 82(1), 35-51. 
Kuno, R., Wang, J., Kawanokuchi, J., Takeuchi, H., Mizuno, T., & Suzumura, A. 
(2005). Autocrine activation of microglia by tumor necrosis factor-alpha. J 
Neuroimmunol, 162(1-2), 89-96. 
Latremoliere, A., & Woolf, C. J. (2009). Central sensitization: a generator of pain 
hypersensitivity by central neural plasticity. J Pain, 10(9), 895-926. 
Leonoudakis, D., Zhao, P., & Beattie, E. C. (2008). Rapid tumor necrosis factor alpha-
induced exocytosis of glutamate receptor 2-lacking AMPA receptors to 
extrasynaptic plasma membrane potentiates excitotoxicity. J Neurosci, 28(9), 
2119-2130. 
Leung, L., & Cahill, C. M. (2010). TNF-alpha and neuropathic pain--a review. J 
Neuroinflammation, 7, 1-27. 
Li, R., Yang, L., Lindholm, K., Konishi, Y., Yue, X., Hampel, H., et al. (2004). Tumor 
necrosis factor death receptor signaling cascade is required for amyloid-beta 
protein-induced neuron death. J Neurosci, 24(7), 1760-1771. 
Lieberman, A. P., Pitha, P. M., Shin, H. S., & Shin, M. L. (1989). Production of tumor 
necrosis factor and other cytokines by astrocytes stimulated with 
lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A, 86(16), 
6348-6352. 
 77 
Liu, Y. L., Zhou, L. J., Hu, N. W., Xu, J. T., Wu, C. Y., Zhang, T., et al. (2007). Tumor 
necrosis factor-alpha induces long-term potentiation of C-fiber evoked field 
potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, 
JNK and p38 MAPK. Neuropharmacology, 52(3), 708-715. 
Lovely, R. G., Gregor, R. J., Roy, R. R., & Edgerton, V. R. (1986). Effects of training on 
the recovery of full-weight-bearing stepping in the adult spinal cat. Exp Neurol, 
92(2), 421-435. 
Mata, M., Hao, S., & Fink, D. J. (2008). Gene therapy directed at the neuroimmune 
component of chronic pain with particular attention to the role of TNF alpha. 
Neurosci Lett, 437(3), 209-213. 
McCoy, M. K., Martinez, T. N., Ruhn, K. A., Szymkowski, D. E., Smith, C. G., 
Botterman, B. R., et al. (2006). Blocking soluble tumor necrosis factor signaling 
with dominant-negative tumor necrosis factor inhibitor attenuates loss of 
dopaminergic neurons in models of Parkinson's disease. J Neurosci, 26(37), 
9365-9375. 
Moalem, G., & Tracey, D. J. (2006). Immune and inflammatory mechanisms in 
neuropathic pain. Brain Res Rev, 51(2), 240-264. 
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994). 
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the 
cerebrospinal fluid from parkinsonian patients. Neurosci Lett, 165(1-2), 208-210. 
Munoz-Fernandez, M. A., & Fresno, M. (1998). The role of tumour necrosis factor, 
interleukin 6, interferon-gamma and inducible nitric oxide synthase in the 
 78 
development and pathology of the nervous system. Prog Neurobiol, 56(3), 307-
340. 
Ogoshi, F., Yin, H. Z., Kuppumbatti, Y., Song, B., Amindari, S., & Weiss, J. H. (2005). 
Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-
permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
(AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal 
neurons. Exp Neurol, 193(2), 384-393. 
Park, K. M., & Bowers, W. J. Tumor necrosis factor-alpha mediated signaling in 
neuronal homeostasis and dysfunction. Cell Signal, 22(7), 977-983. 
Perry, R. T., Collins, J. S., Wiener, H., Acton, R., & Go, R. C. (2001). The role of TNF 
and its receptors in Alzheimer's disease. Neurobiol Aging, 22(6), 873-883. 
Phulwani, N. K., Esen, N., Syed, M. M., & Kielian, T. (2008). TLR2 expression in 
astrocytes is induced by TNF-alpha- and NF-kappa B-dependent pathways. J 
Immunol, 181(6), 3841-3849. 
Pickering, M., Cumiskey, D., & O'Connor, J. J. (2005). Actions of TNF-alpha on 
glutamatergic synaptic transmission in the central nervous system. Exp Physiol, 
90(5), 663-670. 
Rossignol, S., Drew, T., Brustein, E., & Jiang, W. (1999). Locomotor performance and 
adaptation after partial or complete spinal cord lesions in the cat. Prog Brain Res, 
123, 349-365. 
Schafers, M., Geis, C., Svensson, C. I., Luo, Z. D., & Sommer, C. (2003). Selective 
increase of tumour necrosis factor-alpha in injured and spared myelinated 
 79 
primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J 
Neurosci, 17(4), 791-804. 
Schafers, M., Svensson, C. I., Sommer, C., & Sorkin, L. S. (2003). Tumor necrosis 
factor-alpha induces mechanical allodynia after spinal nerve ligation by 
activation of p38 MAPK in primary sensory neurons. J Neurosci, 23(7), 2517-
2521. 
Shafer, R. A., & Murphy, S. (1997). Activated astrocytes induce nitric oxide synthase-2 
in cerebral endothelium via tumor necrosis factor alpha. Glia, 21(4), 370-379. 
Shen, Q., Zhou, D., Ben, Z., Cheng, C., Liu, Y., & Shen, A. (2008). Lipopolysaccharide-
induced upregulation of tumor necrosis factor-alpha (TNF-alpha) in rat spinal 
cord. Inflammation, 31(5), 336-343. 
Sommer, C., Schafers, M., Marziniak, M., & Toyka, K. V. (2001). Etanercept reduces 
hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst, 6(2), 67-
72. 
Sorkin, L. S., Xiao, W. H., Wagner, R., & Myers, R. R. (1997). Tumour necrosis factor-
alpha induces ectopic activity in nociceptive primary afferent fibres. 
Neuroscience, 81(1), 255-262. 
Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & 
O'Callaghan, J. P. (2002). Mice deficient in TNF receptors are protected against 
dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J, 
16(11), 1474-1476. 
 80 
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005). Differential 
regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis 
factor-alpha. J Neurosci, 25(12), 3219-3228. 
Stellwagen, D., & Malenka, R. C. (2006). Synaptic scaling mediated by glial TNF-alpha. 
Nature, 440(7087), 1054-1059. 
Stiene-Martin, A., Mattson, M. P., & Hauser, K. F. (1993). Opiates selectively increase 
intracellular calcium in developing type-1 astrocytes: role of calcium in 
morphine-induced morphologic differentiation. Brain Res Dev Brain Res, 76(2), 
189-196. 
Svensson, C. I., Schafers, M., Jones, T. L., Powell, H., & Sorkin, L. S. (2005). Spinal 
blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. 
Neurosci Lett, 379(3), 209-213. 
Swope, S. L., Moss, S. J., Raymond, L. A., & Huganir, R. L. (1999). Regulation of 
ligand-gated ion channels by protein phosphorylation. Adv Second Messenger 
Phosphoprotein Res, 33, 49-78. 
Tancredi, V., D'Arcangelo, G., Grassi, F., Tarroni, P., Palmieri, G., Santoni, A., et al. 
(1992). Tumor necrosis factor alters synaptic transmission in rat hippocampal 
slices. Neurosci Lett, 146(2), 176-178. 
Tobin, A. M., & Kirby, B. (2005). TNF alpha inhibitors in the treatment of psoriasis and 
psoriatic arthritis. BioDrugs, 19(1), 47-57. 
Tsuda, M., Mizokoshi, A., Shigemoto-Mogami, Y., Koizumi, S., & Inoue, K. (2004). 
Activation of p38 mitogen-activated protein kinase in spinal hyperactive 
 81 
microglia contributes to pain hypersensitivity following peripheral nerve injury. 
Glia, 45(1), 89-95. 
Tsukada, N., Miyagi, K., Matsuda, M., Yanagisawa, N., & Yone, K. (1991). Tumor 
necrosis factor and interleukin-1 in the CSF and sera of patients with multiple 
sclerosis. J Neurol Sci, 104(2), 230-234. 
Turrigiano, G. G. (2008). The self-tuning neuron: synaptic scaling of excitatory 
synapses. Cell, 135(3), 422-435. 
Vichaya, E. G., Baumbauer, K. M., Carcoba, L. M., Grau, J. W., & Meagher, M. W. 
(2009). Spinal glia modulate both adaptive and pathological processes. Brain 
Behav Immun, 23(7), 969-976. 
Wallach, D., Boldin, M., Goncharov, T., Goltsev, Y., Mett, I., Malinin, N., et al. (1996). 
Exploring cell death mechanisms by analyzing signaling cascades of the 
TNF/NGF receptor family. Behring Inst Mitt(97), 144-155. 
Washburn, S. N., Maultsby, M. L., Puga, D. A., & Grau, J. W. (2008). Opioid regulation 
of spinal cord plasticity: evidence the kappa-2 opioid receptor agonist GR89696 
inhibits learning within the rat spinal cord. Neurobiol Learn Mem, 89(1), 1-16. 
Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001). Glial activation: a driving force 
for pathological pain. Trends Neurosci, 24(8), 450-455. 
Wheeler, D., Knapp, E., Bandaru, V. V., Wang, Y., Knorr, D., Poirier, C., et al. (2009). 
Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates 
synaptic plasticity by controlling the membrane insertion of NMDA receptors. J 
Neurochem, 109(5), 1237-1249. 
 82 
Woolf, C. J., & Thompson, S. W. (1991). The induction and maintenance of central 
sensitization is dependent on N-methyl-D-aspartic acid receptor activation; 
implications for the treatment of post-injury pain hypersensitivity states. Pain, 
44(3), 293-299. 
Yarilina, A., Park-Min, K. H., Antoniv, T., Hu, X., & Ivashkiv, L. B. (2008). TNF 
activates an IRF1-dependent autocrine loop leading to sustained expression of 
chemokines and STAT1-dependent type I interferon-response genes. Nat 
Immunol, 9(4), 378-387. 
Youn, D. H., Wang, H., & Jeong, S. J. (2008). Exogenous tumor necrosis factor-alpha 
rapidly alters synaptic and sensory transmission in the adult rat spinal cord dorsal 
horn. J Neurosci Res, 86(13), 2867-2875. 
Young, E. E., Baumbauer, K. M., Elliot, A., & Joynes, R. L. (2007). Lipopolysaccharide 
induces a spinal learning deficit that is blocked by IL-1 receptor antagonism. 
Brain Behav Immun, 21(6), 748-757. 
 
 
 
 
 
 
 
 
 
 83 
VITA 
       
John Russell Huie 
Department of Psychology 
Mail Stop 4235 
College Station, TX 77843   
(979) 862-4852 
russell-huie@tamu.edu        
 
Education: M.S. Texas A&M University, 2007 
  Major:  Psychology 
B.S. Texas A&M University, 2003 
  Major:  Psychology   
   
References: 
Dr. James W. Grau  Dr. Michelle Hook  Dr. Rajesh C. G. Miranda  
Department of Psychology Department of Psychology Dept. of Neuroscience & 
Texas A&M University Texas A&M University Experimental Therapeutics 
College Station, TX 77843 College Station, TX 77843 Texas A&M University 
j-grau@tamu.edu  michelle-hook@tamu.edu Health Science Center 
        College Station, TX  77843 
            miranda@tamu.edu 
Awards: 
Texas A&M University Chapter of the Society for Neuroscience Travel Award  
Texas A&M University Recovery of Function Program Travel Award 
Best Graduate Student Presentation Award, Annual Southwestern Comparative 
Psychology Association Conference, Georgetown, TX April 3-4, 2008. 
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